Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2023

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-38441

ChampionX Corporation

(Exact name of registrant as specified in its charter)


Delaware		82-3066826
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

2445 Technology Forest Blvd,	Building 4, 12th Floor
The Woodlands,	Texas	77381
(Address of principal executive offices)		(Zip Code)

(281) 403-5772

(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common stock, $0.01 par value	CHX	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☑

Accelerated filer

☐

Non-accelerated filer

☐

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑

The registrant had 194.8 million shares of common stock, $0.01 par value, outstanding as of October 19, 2023.

CHAMPIONX CORPORATION

TABLE OF CONTENTS


PART I — FINANCIAL INFORMATION		Page
Item 1.	Financial Statements (unaudited)
	Condensed Consolidated Statements of Income	1
	Condensed Consolidated Statements of Comprehensive Income (Loss)	2
	Condensed Consolidated Balance Sheets	3
	Condensed Consolidated Statements of Changes in Stockholders’ Equity	4
	Condensed Consolidated Statements of Cash Flows	6
	Notes to Condensed Consolidated Financial Statements	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	21
	Executive Overview and Business Outlook	21
	Consolidated Results of Operations	22
	Segment Results of Operations	24
	Capital Resources and Liquidity	26
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	28
Item 4.	Controls and Procedures	28

PART II — OTHER INFORMATION
Item 1.	Legal Proceedings	30
Item 1A.	Risk Factors	30
Item 2.	Unregistered Sales of Equity Securities , Use of Proceeds, and Issuer Purchases of Equity Securities	30
Item 3.	Defaults Upon Senior Securities	30
Item 4.	Mine Safety Disclosures	30
Item 5.	Other Information	31
Item 6.	Exhibits	32
SIGNATURES		33

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, contained in this report are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements usually relate to future events and anticipated revenues, earnings, cash flows or other aspects of our operations or operating results. Forward-looking statements are often identified by the words “believe,” “anticipate,” “expect,” “may,” “intend,” “foresee,” “guidance,” “estimate,” “potential,” “outlook,” “plan,” “should,” “would,” “could,” “target,” “forecast” and similar expressions, including the negative thereof. The absence of these words, however, does not mean that the statements are not forward-looking statements. Forward-looking statements are based on our current expectations, beliefs and assumptions concerning future developments and business conditions and their potential effect on us. While management believes that these forward-looking statements are reasonable as and when made, there can be no assurance that future developments affecting us will be those that we anticipate.

All of our forward-looking statements involve risks, uncertainties and assumptions (some of which are significant or beyond our control) that could cause actual results to materially differ from our historical experience and our present expectations or projections. Known material factors that could cause actual results to materially differ from those contemplated in the forward-looking statements are those set forth in Part I, Item 1A, “Risk Factors,” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 and in Part II, Item 1A, “Risk Factors,” in this Quarterly Report on Form 10-Q, and include the following:

•Demand for, and profitability of our products and services, is affected by changes in the price of, and demand for, crude oil and natural gas in domestic and international markets;

•Cost inflation and availability of raw materials;

•The impact of inflation on wholesale product costs, labor rates, transportation costs, and on our customers’ financial position and ability to purchase our products;

•Global economic conditions, geopolitical issues, supply chain disruptions, and availability and cost of credit, and the impact thereof on our operations and those of our customers and suppliers;

•Our ability to successfully compete with other companies in our industry;

•Our ability to develop and implement or introduce new technologies, products, and services, as well as our ability to protect and maintain intellectual property assets;

•Our ability to successfully execute potential acquisitions and integrate acquired businesses;

•Potential liabilities arising out of the installation, use or manufacturing of our products or from a chemical spill or release;

•Manufacturing disruptions, particularly with respect to our chemical products, including as a result of fires, explosions and chemical spills, releases or discharges;

•Continuing consolidation within our customers’ industry;

•Credit risks related to our customer base or the loss of significant customers;

•A failure of our information technology infrastructure or any significant breach of security;

•Risks relating to our existing international operations and expansion into new geographical markets;

•Risks relating to improper conduct by any of our employees, agents or business partners;

•Failure to attract, retain and develop personnel;

•The impact of natural disasters and other unusual weather conditions on our business;

•Investor sentiment towards companies in the oil and gas industry due to climate change, fossil fuels and other environmental, social and governance matters;

•Changes in domestic and foreign governmental public policies and actions of governments that impact oil and gas operations or favor renewable energy projects, risks associated with entry into emerging markets, changes in statutory tax rates and unanticipated outcomes with respect to tax audits;

•Disruptions in the political, regulatory, economic and social conditions of the countries in which we conduct business;

•Fluctuations in currency markets worldwide

•The impact of our indebtedness on our financial position and operating flexibility;

•Disruptions in the capital and credit markets;

•The impact of war, terrorism and civil unrest;

•Risks relating to information technology and cybersecurity, including the potential for cyberattacks or security breaches that could disrupt our or our partners’ or suppliers’ operations, compromise confidential or otherwise protected information, damage our reputation, expose us to legal liability, or cause financial losses;

•Changes in federal, state and local legislation and regulations relating to oil and gas development and the potential for related litigation or restrictions on our customers;

•Changes in environmental and health and safety laws and regulations which may increase our costs, limit the demand for our products and services or restrict our operations; and

•The impact of tariffs and other trade measures on our business.

We wish to caution you not to place undue reliance on any forward-looking statements, which speak only as of the date hereof. We undertake no obligation to publicly update, revise or correct any of our forward-looking statements after the date they are made, whether as a result of new information, future events or otherwise, except to the extent required under the federal securities laws.

PART I — FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

CHAMPIONX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)


	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands, except per share data)	2023		2022		2023		2022
Revenue:
Product revenue	$	827,659	$	897,156	$	2,474,098	$	2,455,377
Service revenue	86,849		101,598		268,739		299,835
Lease and other revenue	25,275		22,807		71,893		64,881
Total revenue	939,783		1,021,561		2,814,730		2,820,093
Cost of goods and services	647,923		825,018		1,957,309		2,204,052
Gross profit	291,860		196,543		857,421		616,041
Costs and expenses:
Selling, general and administrative expense	162,317		153,736		485,617		445,447

Loss (gain) on disposal group	—		(6,409)		12,965		16,515
Interest expense, net	13,744		11,454		40,754		33,582
Other expense, net	5,998		291		8,189		10,968
Income before income taxes	109,801		37,471		309,896		109,529
Provision for income taxes	29,009		14,246		69,334		19,235
Net income	80,792		23,225		240,562		90,294
Net income attributable to noncontrolling interest	3,081		157		3,522		3,182
Net income attributable to ChampionX	$	77,711	$	23,068	$	237,040	$	87,112

Earnings per share attributable to ChampionX:
Basic	$	0.40	$	0.11	$	1.20	$	0.43
Diluted	$	0.39	$	0.11	$	1.18	$	0.42
Weighted-average shares outstanding:
Basic	195,881		201,421		197,058		202,600
Diluted	199,592		206,522		201,025		208,155

The accompanying notes are an integral part of the condensed consolidated financial statements.

CHAMPIONX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(Unaudited)


	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Net income	$	80,792	$	23,225	$	240,562	$	90,294
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	(13,144)		(47,067)		(14,800)		(27,463)
Cash flow hedges	6,164		16,310		1,706		11,608
Defined pension and other post-retirement benefits adjustments, net	59		68		10		207
Other comprehensive loss	(6,921)		(30,689)		(13,084)		(15,648)
Comprehensive income (loss)	73,871		(7,464)		227,478		74,646
Less: Comprehensive income attributable to noncontrolling interest	3,081		157		3,522		3,182
Comprehensive income (loss) attributable to ChampionX	$	70,790	$	(7,621)	$	223,956	$	71,464

The accompanying notes are an integral part of the condensed consolidated financial statements.

CHAMPIONX CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)


(in thousands, except share data)	September 30, 2023		December 31, 2022
ASSETS
Current Assets:
Cash and cash equivalents	$	285,006	$	250,187
Receivables, net of allowances of $6,148 in 2023 and $5,148 in 2022	520,106		601,061
Inventories, net	588,800		542,543
Assets held for sale	9,959		29,334
Prepaid expenses and other current assets	81,825		75,456
Total current assets	1,485,696		1,498,581
Property, plant, and equipment, net of accumulated depreciation of $751,939 in 2023 and $693,226 in 2022	763,559		734,810
Goodwill	666,108		679,488
Intangible assets, net	256,376		305,010
Operating lease right-of-use assets	75,924		92,928

Other non-current assets	63,541		76,666

Total assets	$	3,311,204	$	3,387,483
LIABILITIES AND EQUITY
Current Liabilities:
Current portion of long-term debt	$	6,250	$	6,250
Accounts payable	500,021		469,566
Accrued compensation and employee benefits	90,772		102,750
Current portion of operating lease liabilities	24,586		28,838
Accrued distributor fees	38,531		102,034
Liabilities held for sale	—		7,186
Accrued expenses and other current liabilities	133,716		142,352
Total current liabilities	793,876		858,976
Long-term debt	594,943		621,702
Deferred income taxes	77,457		94,235
Operating lease liabilities	46,162		59,686
Other long-term liabilities	92,638		75,669
Total liabilities	1,605,076		1,710,268
Stockholders’ equity:
Common stock (2.5 billion shares authorized, $0.01 par value) 195.0 million shares and 198.5 million shares issued and outstanding in 2023 and 2022, respectively	1,950		1,985
Capital in excess of par value of common stock	2,204,974		2,249,698

Accumulated deficit	(442,831)		(527,603)
Accumulated other comprehensive loss	(42,614)		(29,530)
ChampionX stockholders’ equity	1,721,479		1,694,550
Noncontrolling interest	(15,351)		(17,335)
Total equity	1,706,128		1,677,215
Total liabilities and equity	$	3,311,204	$	3,387,483

The accompanying notes are an integral part of the condensed consolidated financial statements.

CHAMPIONX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(Unaudited)


	Common Stock
(in thousands)	Shares	Par Value		Capital in Excess of Par Value		Accum. Deficit		Accum. Other Comp. Loss		Non-controlling Interest		Total
December 31, 2022	198,466	$	1,985	$	2,249,698	$	(527,603)	$	(29,530)	$	(17,335)	$	1,677,215
Net income	—	—		—		63,532		—		(388)		63,144
Other comprehensive loss	—	—		—		—		(15,312)		—		(15,312)
Stock-based compensation	327	3		5,231		—		—		—		5,234
Stock options exercised	481	5		3,009		—		—		—		3,014
Taxes withheld on issuance of stock-based awards	—	—		(5,100)		—		—		—		(5,100)
Dividends declared to common stockholders ($0.085 per share)	—	—		—		(16,784)		—		—		(16,784)
Repurchase and cancellation of common stock	(1,302)	(13)		(14,811)		(25,603)		—		—		(40,427)
Distributions to noncontrolling interest	—	—		—		—		—		(823)		(823)
Cumulative translation adjustments	—	—		—		—		—		8		8
March 31, 2023	197,972	$	1,980	$	2,238,027	$	(506,458)	$	(44,842)	$	(18,538)	$	1,670,169
Net income	—	—		—		95,797		—		829		96,626
Other comprehensive income	—	—		—		—		9,149		—		9,149
Stock-based compensation	180	2		6,339		—		—		—		6,341
Stock options exercised	27	—		24		—		—		—		24
Taxes withheld on issuance of stock-based awards	—	—		(2,039)		—		—		—		(2,039)
Dividends declared to common stockholders ($0.085 per share)	—	—		—		(16,758)		—		—		(16,758)
Repurchase and cancellation of common stock	(1,883)	(19)		(21,442)		(29,729)		—		—		(51,190)



June 30, 2023	196,296	$	1,963	$	2,220,909	$	(457,148)	$	(35,693)	$	(17,709)	$	1,712,322
Net income	—	—		—		77,711				3,081		80,792
Other comprehensive loss	—	—		—		—		(6,921)		—		(6,921)
Stock-based compensation	129	1		6,088		—		—		—		6,089
Stock options exercised	444	5		2,754		—		—		—		2,759
Taxes withheld on issuance of stock-based awards	—	—		(2,593)		—		—		—		(2,593)
Dividends declared to common stockholders ($0.085 per share)	—	—		—		(16,718)		—		—		(16,718)
Repurchase and cancellation of common stock	(1,883)	(19)		(21,418)		(46,676)		—		—		(68,113)
Distributions to noncontrolling interest	—	—		(766)		—		—		(716)		(1,482)
Cumulative translation adjustments	—	—		—		—		—		(7)		(7)

September 30, 2023	194,986	$	1,950	$	2,204,974	$	(442,831)	$	(42,614)	$	(15,351)	$	1,706,128


	Common Stock
(in thousands)	Shares	Par Value		Capital in Excess of Par Value		Accum. Deficit		Accum. Other Comp. Loss		Non-controlling Interest		Total
December 31, 2021	202,866	$	2,029	$	2,315,399	$	(525,158)	$	(21,625)	$	(16,338)	$	1,754,307
Net income	—	—		—		36,702		—		1,471		38,173
Other comprehensive loss	—	—		—		—		(2,795)		—		(2,795)
Stock-based compensation	290	3		4,725		—		—		—		4,728
Stock options exercised	189	1		1,054		—		—		—		1,055
Taxes withheld on issuance of stock-based awards	—	—		(2,639)		—		—		—		(2,639)
Dividends declared to common stockholders ($0.075 per share)	—	—		—		(15,465)		—		—		(15,465)


Cumulative translation adjustments	—	—		—		—		—		208		208

March 31, 2022	203,345	$	2,033	$	2,318,539	$	(503,921)	$	(24,420)	$	(14,659)	$	1,777,572
Net income	—	—		—		27,342		—		1,554		28,896
Other comprehensive income	—	—		—		—		17,836		—		17,836
Stock-based compensation	64	1		5,070		—		—		—		5,071
Stock options exercised	312	3		2,087		—		—		—		2,090
Taxes withheld on issuance of stock-based awards	—	—		(739)		—		—		—		(739)
Dividends declared to common stockholders ($0.075 per share)	—	—		—		(15,494)		—		—		(15,494)
Repurchase and cancellation of common stock	(790)	(8)		(8,992)		(11,016)		—		—		(20,016)
Distributions to noncontrolling interest	—	—		—		—		—		(2,369)		(2,369)
Cumulative translation adjustments	—	—		—		—		—		8		8

June 30, 2022	202,931	$	2,029	$	2,315,965	$	(503,089)	$	(6,584)	$	(15,466)	$	1,792,855
Net income	—	—		—		23,068		—		157		23,225
Other comprehensive loss	—	—		—		—		(30,689)		—		(30,689)
Stock-based compensation	20	—		5,009		—		—		—		5,009
Stock options exercised	87	1		563		—		—		—		564
Taxes withheld on issuance of stock-based awards	—	—		(198)		—		—		—		(198)
Dividends declared to common stockholders ($0.075 per share)	—	—		—		(15,315)		—		—		(15,315)
Repurchase and cancellation of common stock	(3,698)	(37)		(45,245)		(34,792)		—		—		(80,074)
Distributions to noncontrolling interest	—	—		—		—		—		(647)		(647)
Cumulative translation adjustments	—	—		—		—		—		(10)		(10)

September 30, 2022	199,340	$	1,993	$	2,276,094	$	(530,128)	$	(37,273)	$	(15,966)	$	1,694,720

The accompanying notes are an integral part of the condensed consolidated financial statements.

CHAMPIONX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)


	Nine Months Ended September 30,
(in thousands)	2023		2022
Cash flows from operating activities:
Net income	$	240,562	$	90,294
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization	177,226		177,761
Loss on disposal group	12,965		16,515


Stock-based compensation	17,664		14,808
Provision for inventory obsolescence and write-downs	16,354		21,214
Loss on debt extinguishment	—		4,043
Deferred income taxes	(15,380)		(37,505)
Gain on disposal of fixed assets	(1,480)		(4,428)

Amortization of deferred loan costs and accretion of discount	3,044		2,736

Other	4,791		1,261
Changes in operating assets and liabilities (net of effects of foreign exchange):
Receivables	85,181		(50,075)
Inventories	(50,011)		(72,298)
Leased assets	(38,597)		(20,947)
Other assets	17,470		24,022
Accounts payable	(7,018)		38,600
Other liabilities	(91,453)		12,266






Net cash flows provided by operating activities	371,318		218,267

Cash flows from investing activities:
Capital expenditures	(110,965)		(74,752)
Proceeds from sale of fixed assets	12,328		16,424

Acquisitions, net of cash acquired	—		(3,198)


Net cash used for investing activities	(98,637)		(61,526)

Cash flows from financing activities:
Proceeds from long-term debt	15,500		995,038
Repayment of long-term debt	(43,625)		(1,071,386)
Payment of debt issue costs	(1,028)		(8,008)
Repurchases of common stock	(159,730)		(100,090)
Dividends paid	(48,309)		(30,480)
Payments related to taxes withheld on stock-based compensation	(9,732)		(3,576)
Proceeds from exercise of stock options	5,797		3,709
Payment of finance lease obligations	(7,148)		(4,503)
Distributions to noncontrolling interest	(2,305)		(3,016)
Proceeds expected to be remitted under the Accounts Receivable Facility	14,032		7,111

Net cash used for financing activities	(236,548)		(215,201)






Effect of exchange rate changes on cash and cash equivalents	(1,314)		(5,746)

Net increase (decrease) in cash and cash equivalents	34,819		(64,206)
Cash and cash equivalents at beginning of period	250,187		255,178
Cash and cash equivalents at end of period	$	285,006	$	190,972

The accompanying notes are an integral part of the condensed consolidated financial statements.

CHAMPIONX CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

NOTE 1—BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Description of the Business

ChampionX Corporation is a global leader in chemistry solutions, artificial lift systems, and highly engineered equipment and technologies that help companies drill for and produce oil and gas safely, efficiently, and sustainably around the world. Our expertise, innovative products, and digital technologies provide enhanced oil and gas production, transportation, and real-time emissions monitoring throughout the lifecycle of a well.

Unless the context requires otherwise, references in this report to “we,” “us,” “our,” “the Company,” or “ChampionX” mean ChampionX Corporation, together with its subsidiaries where the context requires.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements of ChampionX have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission pertaining to interim financial information. As permitted under those rules, certain footnotes or other financial information that are normally required by GAAP have been condensed or omitted. Therefore, these financial statements should be read in conjunction with the audited consolidated financial statements, and notes thereto, which are included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022.

The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Although these estimates are based on management’s best knowledge of current events and actions that we may undertake in the future, actual results may differ from our estimates. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments unless otherwise specified) necessary for a fair statement of our financial condition and results of operations as of and for the periods presented. Revenue, expenses, assets and liabilities can vary during each quarter of the year. Therefore, the results and trends in these financial statements may not be representative of the results that may be expected for the year ending December 31, 2023.

Significant Accounting Policies

Please refer to “Note 1–Basis of Presentation and Summary of Significant Accounting Policies” to our consolidated financial statements in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 for the discussion of our significant accounting policies.

New Accounting Standards Issued

In September 2022, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2022-04, “Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations,” which requires that a buyer in a supplier finance program disclose information about the key terms of the program, outstanding confirmed amounts as of the end of the period, a rollforward of such amounts during each annual period, and a description of where in the financial statements outstanding amounts are presented. The ASU does not affect the recognition, measurement or financial statement presentation of obligations covered by supplier finance programs. The guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023, with early adoption permitted.

The adoption of this ASU did not have a material effect on our consolidated financial statements, other than the newly required disclosures. See Note 15—Supply Chain Finance for information on our supplier finance program.

NOTE 2—SEGMENT INFORMATION

Our reporting segments are:

•Production Chemical Technologies—provides oil and natural gas production and midstream markets with solutions to manage and control corrosion, oil and water separation, flow assurance, sour gas treatment and a host of water-related issues.

•Production & Automation Technologies—designs, manufactures, markets and services a full range of artificial lift equipment, end-to-end digital automation solutions, as well as other production equipment and asset monitoring technologies. Production & Automation Technologies’ products are sold under a collection of brands including Harbison-Fischer, Norris, Alberta Oil Tool, Oil Lift Technology, PCS Ferguson, Pro-Rod, Upco, Unbridled ESP, Norriseal-Wellmark, Quartzdyne, Spirit, Theta, Timberline and Windrock.

•Drilling Technologies—designs, manufactures and markets polycrystalline diamond cutters and bearings for use in oil and gas drill bits under the US Synthetic brand.

•Reservoir Chemical Technologies—manufactures specialty products that support well stimulation, construction (including drilling and cementing) and remediation needs in the oil and natural gas industry.

We refer to our Production Chemical Technologies segment and our Reservoir Chemical Technologies segment collectively as our Chemical Technologies business. Although Reservoir Chemical Technologies is not required to be disclosed separately as a reportable segment based on materiality, management believes the additional information may contribute to a better understanding of the business. Other business activities that do not meet the criteria of an operating segment have been combined into Corporate and other. Corporate and other includes (i) corporate and overhead expenses, and (ii) revenue and costs for activities that are not operating segments.

Segment revenue and segment operating profit


	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Segment revenue:
Production Chemical Technologies	$	604,254	$	643,604	$	1,770,240	$	1,710,987
Production & Automation Technologies	256,148		247,717		761,852		710,465
Drilling Technologies	54,869		60,965		168,900		175,682
Reservoir Chemical Technologies	25,093		35,485		74,752		119,499
Corporate and other (1)	(581)		33,790		38,986		103,460
Total revenue	$	939,783	$	1,021,561	$	2,814,730	$	2,820,093

Segment operating profit (loss):
Production Chemical Technologies	$	94,560	$	86,649	$	248,037	$	143,518
Production & Automation Technologies	28,299		22,485		96,299		70,845
Drilling Technologies	12,255		14,856		36,802		45,119
Reservoir Chemical Technologies	2,461		(61,711)		6,634		(73,327)
Total segment operating profit	137,575		62,279		387,772		186,155
Corporate and other (1)	14,030		13,354		37,122		43,044
Interest expense, net	13,744		11,454		40,754		33,582
Income before income taxes	$	109,801	$	37,471	$	309,896	$	109,529

_______________________

(1) Corporate and other includes costs not directly attributable or allocated to our reporting segments such as overhead and other costs pertaining to corporate executive management and other administrative functions, and the results attributable to our noncontrolling interest. Additionally, the sales and expenses related to the Cross Supply and Product Transfer Agreement with Ecolab Inc. (“Ecolab”) were included within Corporate and other from June 3, 2020, the date we acquired the Chemical Technologies business from Ecolab, through June 30, 2023. Beginning July 1, 2023, these sales and expenses are recognized in the Production Chemical Technologies segment.

NOTE 3—REVENUE

Our revenue is generated primarily from product sales. Service revenue is generated from providing services to our customers. These services include installation, repair and maintenance, laboratory and logistics services, chemical management services, troubleshooting, reporting, water treatment services, technical advisory assistance, emissions detection and monitoring, and other field services. Lease revenue is derived from rental income of leased production equipment. As our costs are shared across the various revenue categories, cost of goods sold is not tracked separately and is not discretely identifiable.

In certain geographical areas, the Company utilizes joint ventures and independent third-party distributors and sales agents to sell and market products and services. Amounts payable to independent third-party distributors and sales agents may fluctuate based on sales and timing of distributor fee payments. For services rendered by such independent third-party distributors and sales agents, the Company records the consideration received on a net basis within product revenue in our condensed consolidated statements of income. Additionally, amounts owed to distributors and sales agents are reported within accrued distributor fees within our consolidated balance sheets.

Revenue disaggregated by geography was as follows:


	Three Months Ended September 30, 2023
(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Corporate and other (1)		Total
United States	$	250,980	$	191,139	$	41,314	$	14,131	$	(30)	$	497,534
Latin America	136,714		5,400		—		2,821		—		144,935
Middle East & Africa	75,086		17,889		2,218		6,959		(547)		101,605
Canada	73,107		20,362		3,661		257		—		97,387
Europe	47,791		4,680		6,289		714		(4)		59,470
Asia-Pacific	15,075		3,846		1,387		199		—		20,507
Australia	5,501		12,832		—		12		—		18,345
Other	—		—		—		—		—		—
Total revenue	$	604,254	$	256,148	$	54,869	$	25,093	$	(581)	$	939,783

	Three Months Ended September 30, 2022
(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Corporate and other (1)		Total
United States	$	228,007	$	192,914	$	47,645	$	19,756	$	19,651	$	507,973
Latin America	184,964		4,963		7		3,283		758		193,975
Middle East & Africa	77,162		15,567		1,562		8,314		1,358		103,963
Canada	75,334		18,922		4,614		334		49		99,253
Europe	50,206		2,776		5,774		1,102		3,584		63,442
Asia-Pacific	8,851		1,528		1,363		767		8,390		20,899
Australia	5,518		10,803		—		30		—		16,351
Other	13,562		244		—		1,899		—		15,705
Total revenue	$	643,604	$	247,717	$	60,965	$	35,485	$	33,790	$	1,021,561


	Nine Months Ended September 30, 2023
(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Corporate and other (1)		Total
United States	$	729,658	$	581,335	$	128,507	$	38,381	$	20,574	$	1,498,455
Latin America	377,268		15,545		—		9,833		1,719		404,365
Middle East & Africa	233,849		48,066		7,666		20,819		(985)		309,415
Canada	219,674		56,547		10,350		1,215		18		287,804
Europe	151,009		14,619		18,993		1,857		5,121		191,599
Asia-Pacific	32,866		9,451		3,382		2,070		12,539		60,308
Australia	16,586		36,289		—		14		—		52,889
Other	9,330		—		2		563		—		9,895
Total revenue	$	1,770,240	$	761,852	$	168,900	$	74,752	$	38,986	$	2,814,730

	Nine Months Ended September 30, 2022
(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Corporate and other (1)		Total
United States	$	624,370	$	548,698	$	140,312	$	76,015	$	61,544	$	1,450,939
Latin America	409,109		16,324		7		10,094		2,388		437,922
Middle East & Africa	227,234		51,340		4,471		21,596		1,959		306,600
Canada	223,714		55,858		11,032		1,445		112		292,161
Europe	145,116		8,505		14,640		2,973		10,352		181,586
Asia-Pacific	26,852		3,983		5,180		2,721		27,105		65,841
Australia	16,321		25,386		15		229		—		41,951
Other	38,271		371		25		4,426		—		43,093
Total revenue	$	1,710,987	$	710,465	$	175,682	$	119,499	$	103,460	$	2,820,093

______________________

(1) The sales related to the Cross Supply and Product Transfer Agreement with Ecolab were included within Corporate and other from the date we acquired the Chemical Technologies business from Ecolab through June 30, 2023. Beginning July 1, 2023, these sales and expenses are recognized in the Production Chemical Technologies segment.

Revenue is attributed to regions based on the location of our direct customer, which in some instances is an intermediary and not necessarily the end user.

Contract Balances

The beginning and ending contract asset and contract liability balances from contracts with customers were as follows:


(in thousands)	September 30, 2023		December 31, 2022
Contract assets	$	—	$	—
Contract liabilities - current	$	25,875	$	14,113

NOTE 4—INTANGIBLE ASSETS AND GOODWILL

Intangible Assets

The components of our definite- and indefinite-lived intangible assets were as follows:


	September 30, 2023						December 31, 2022
(in thousands)	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Definite-lived intangible assets:
Customer relationships	$	582,095	$	429,885	$	152,210	$	582,466	$	407,212	$	175,254
Unpatented technologies	142,760		70,504		72,256		142,760		56,264		86,496
Favorable supply agreements	57,000		57,000		—		57,000		49,056		7,944
Trademarks	59,856		38,750		21,106		59,856		36,048		23,808
Patents	36,244		30,240		6,004		38,175		31,481		6,694
Other	525		525		—		1,892		1,878		14
	878,480		626,904		251,576		882,149		581,939		300,210
Indefinite-lived intangible assets:
Trademarks	3,600		—		3,600		3,600		—		3,600
In-process research and development	1,200		—		1,200		1,200		—		1,200
	4,800		—		4,800		4,800		—		4,800
Total	$	883,280	$	626,904	$	256,376	$	886,949	$	581,939	$	305,010

Goodwill

The carrying amount of goodwill, including changes therein, by reportable segment is below:


(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Total
December 31, 2022	$	367,084	$	211,268	$	101,136	$	—	$	679,488



Foreign currency translation	(13,328)		(52)		—		—		(13,380)
September 30, 2023	$	353,756	$	211,216	$	101,136	$	—	$	666,108

Goodwill is not subject to amortization but is tested for impairment on an annual basis or more frequently if impairment indicators arise.

NOTE 5—DEBT

Long-term debt consisted of the following:


(in thousands)	September 30, 2023		December 31, 2022
2022 Revolving Credit Facility	$	—	$	25,000
2022 Term Loan Facility	620,312		623,438
Total	620,312		648,438
Net unamortized discounts and issuance costs	(19,119)		(20,486)
Total long-term debt	601,193		627,952
Current portion of long-term debt (1)	(6,250)		(6,250)
Long-term debt, less current portion	$	594,943	$	621,702

_______________________

(1) Includes the mandatory amortization payments due within twelve months related to the 2022 Term Loan Facility as of September 30, 2023.

On June 7, 2022, we entered into a restated credit agreement (the “Restated Credit Agreement”), which provides for (i) a $625.0 million seven-year senior secured term loan B facility (the “2022 Term Loan Facility”) and (ii) a five-year senior secured revolving credit facility in an aggregate principal amount of $700.0 million, of which $100.0 million is available for the issuance of letters of credit (the “2022 Revolving Credit Facility,” and, together with the 2022 Term Loan Facility, the “Senior Secured Credit Facility”). The full amount of the 2022 Term Loan Facility was funded, and $135.0 million of the 2022 Revolving Credit Facility was drawn, on June 7, 2022. As of September 30, 2023, we had no outstanding balance on the 2022 Revolving Credit Facility.

The 2022 Term Loan Facility matures June 7, 2029 and the 2022 Revolving Credit Facility matures June 7, 2027. The 2022 Term Loan Facility is subject to mandatory amortization payments of 1% per annum of the initial commitment paid quarterly. The Senior Secured Credit Facility contains customary representations and warranties, covenants, and events of default for loan facilities of this type. We were in compliance with all covenants as of September 30, 2023.

At the Company’s election, outstanding borrowings under the Senior Secured Credit Facility will accrue interest at a per annum rate of (i) an adjusted SOFR rate plus the applicable spread or (ii) a base rate plus the applicable spread. On September 29, 2023, we amended the Restated Credit Agreement to, among other things, reprice the Company’s $620.3 million of existing term loans under the 2022 Term Loan Facility, in connection with which new term loans in the same amount were issued. The new term loans bear interest at a per annum rate of (i) an adjusted SOFR Rate plus 2.75% per annum or (ii) a base rate plus 1.75%. The new term loans may be prepaid at any time without penalty, other than a 1.00% premium if the loans are repriced at any time prior to March 30, 2024 and subject to the payment of customary breakage costs in the case of the SOFR rate loans. All other material terms of the Senior Secured Credit Facility remain unchanged.

On June 29, 2022, the Company executed a five-year amortizing floating-to-fixed interest rate swap to hedge our exposure to increases in variable interest rates on the 2022 Term Loan Facility. This interest rate swap agreement is based on a $300.0 million notional amount for the first three years, reducing to $150.0 million for years four and five. See Note 12—Derivatives and Hedging Transactions for additional information on interest rate swaps.

NOTE 6—COMMITMENTS AND CONTINGENCIES

The Company is subject to various claims and contingencies related to, among other things, workers’ compensation, general liability (including product liability), automobile claims, health care claims, environmental matters, and lawsuits. We record liabilities where a contingent loss is probable and can be reasonably estimated. If the reasonable estimate of a probable loss is a range, the Company records the most probable estimate of the loss or the minimum amount when no amount within the range is a better estimate than any other amount. In accordance with applicable GAAP, the Company discloses a contingent liability even if the liability is not probable or the amount is not estimable, or both, if there is a reasonable possibility that a material loss may have been incurred.

Guarantees and Indemnifications

We have provided indemnities in connection with sales of certain businesses and assets, including indemnities for environmental health and safety, tax, and employment matters. We do not have any material liabilities recorded for these indemnifications and are not aware of any claims or other information that would give rise to material payments under such indemnities.

As of September 30, 2023 and December 31, 2022, we had $78.3 million and $82.4 million, respectively, of outstanding letters of credit, surety bonds and guarantees, which expire at various dates through 2039. These financial instruments are primarily maintained as security for insurance, warranty, and other performance obligations. Generally, we would only be liable for the amount of these letters of credit, surety bonds, and guarantees in the event of default in the performance of our obligations, the probability of which we believe is remote.

Litigation and Environmental Matters

The Company is party to various proceedings and claims incidental to its business, including matters arising under provisions relating to the protection of the environment. We review the probable outcome of such proceedings, the costs and expenses reasonably expected to be incurred and accrued to date, and the availability and extent of insurance coverage. We accrue a liability for legal matters that are probable and can be reasonably estimated. If the reasonable estimate of a probable loss is a range, the Company records the most probable estimate of the loss or the minimum amount when no amount within the range is a better estimate than any other amount. While many of these matters involve inherent uncertainty, we believe that the amount of the liability, if any, ultimately incurred with respect to these proceedings and claims will not have a material adverse effect on our consolidated financial position, results of operations or cash flows.

Environmental Matters

The Company is currently participating in environmental assessments and remediation at approximately 8 locations, the majority of which are in the United States (“U.S.”). Environmental liabilities have been accrued to reflect our best estimate of future costs. Potential insurance reimbursements are not anticipated in the Company’s accruals for environmental liabilities. As of September 30, 2023 and December 31, 2022, environmental liability accruals related to these locations were $5.9 million and $5.9 million, respectively.

Prior to the commencement of our operations as an independent publicly traded company in 2018, groundwater contamination was discovered at the Norris Sucker Rods plant site located in Tulsa, Oklahoma. Initial remedial efforts were undertaken at the time of discovery of the contamination and we have since coordinated monitoring and remediation with the Oklahoma Department of Environmental Quality (“ODEQ”). As part of the ongoing long-term remediation process, we contracted an engineering and consulting firm to develop a range of possible additional remedial alternatives in order to accelerate the remediation process and associated cost estimates for the work. In October 2019, we received the firm’s preliminary remedial alternatives for consideration. We have submitted our long-term remediation plan and it was approved by ODEQ. We are now in discussion with ODEQ to finalize a consent order. Because we have not yet finalized the consent order for further remediation at the site and discussions with ODEQ remain ongoing, we cannot fully anticipate the timing, outcome or possible impact of such further remedial activities, financial or otherwise. As a result of the recommendations in the report, we accrued liabilities for these remediation efforts of approximately $2.0 million as of December 31, 2019. Liabilities could increase in the future at such time as we ultimately reach agreement with ODEQ on our remediation plan and such liabilities become probable and can be reasonably estimated; however, there have been no changes to our estimated liability as of September 30, 2023.

Matters Related to Deepwater Horizon Incident Response

On April 22, 2010, the deepwater drilling platform, the Deepwater Horizon, operated by a subsidiary of BP plc, sank in the Gulf of Mexico after an explosion and fire, resulting in a massive oil spill. Certain entities that are now subsidiaries of ChampionX as a result of the acquisition of the Chemical Technologies business in 2020 (collectively the “COREXIT Defendants”) supplied COREXIT™ 9500, an oil dispersant product listed on the U.S. EPA National Contingency Plan Product Schedule, which was used in the response to the spill. In connection with the provision of COREXIT™ 9500, the COREXIT Defendants were named in several lawsuits. Cases arising out of the Deepwater Horizon accident were administratively transferred and consolidated for pre-trial purposes under In Re: Oil Spill by the Oil Rig “Deepwater Horizon” in the Gulf of Mexico, on April 20, 2010, Case No. 10-md-02179 in the United States District Court in the Eastern District of Louisiana (E.D. La.) (“MDL 2179”). Claims related to the response to the oil spill were consolidated in a master complaint captioned the “B3 Master Complaint.” In 2011, Transocean Deepwater Drilling, Inc. and its affiliates (the “Transocean Entities”) named the COREXIT Defendants and other unaffiliated companies as first party defendants (In re the Complaint and Petition of Triton Asset Leasing GmbH, et al, MDL No. 2179, Civil Action 10-2771). In April and May 2011, the Transocean Entities, Cameron International Corporation, Halliburton Energy Services, Inc., M-I L.L.C., Weatherford U.S., L.P. and Weatherford International, Inc. (collectively, the “Cross Claimants”) filed cross claims in MDL 2179 against the COREXIT Defendants and other unaffiliated cross defendants. In April and June 2011, in support of its defense of the claims against it, the COREXIT Defendants filed counterclaims against the Cross Claimants. On May 18, 2012, the COREXIT Defendants filed a motion for summary judgment as to the claims in the B3 Master Complaint. On November 28, 2012, the Court granted the COREXIT Defendants’ motion and dismissed with prejudice the claims in the B3 Master Complaint asserted against the COREXIT Defendants. There currently remains one “B3” case that asserted claims against the COREXIT Defendants and that remains pending against other defendants. Because the Court’s decision was not a “final judgment” for purposes of appeal with respect to those claims, under Federal Rule of Appellate Procedure 4(a), the plaintiff will have 30 days after entry of final judgment in the case to appeal the Court’s summary judgment decision.

The Company intends to vigorously defend these lawsuits and also believes that it has rights to contribution and/or indemnification (including legal expenses) from third parties. However, we cannot predict the outcome of these lawsuits, the involvement it might have in these matters in the future, or the potential for future litigation.

NOTE 7—RESTRUCTURING EXPENSE

We approved various restructuring plans related to the consolidation of product lines and associated facility closures and workforce reductions during prior periods, which we expect to be completed during 2023. We recognized charges of $0.1 million and $6.3 million during the three and nine months ended September 30, 2023, respectively, consisting primarily of contract termination costs, inventory obsolescence, and employee severance and related benefits. During the three and nine months ended September 30, 2022, we recorded restructuring expense of $69.8 million and $84.9 million, respectively.

The following table presents the restructuring expense by segment as classified in our condensed consolidated statements of income.


	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Segment restructuring expense (income):
Production Chemical Technologies	$	58	$	(335)	$	4,636	$	11,637
Production & Automation Technologies	—		4,282		785		260
Drilling Technologies	—		—		—		—
Reservoir Chemical Technologies	32		63,458		855		69,559
Corporate and other	—		2,350		4		3,403
Total	$	90	$	69,755	$	6,280	$	84,859

Statements of Income classification:
Cost of goods and services	$	29	$	66,488	$	2,573	$	67,496
Selling, general and administrative expense	61		3,267		3,707		17,363
Total	$	90	$	69,755	$	6,280	$	84,859

Our liability balance for restructuring expense at September 30, 2023 reflects contract termination costs, employee severance and related benefits initiated during the period. Additional programs may be initiated during the remainder of 2023 with related restructuring charges.

The following table details our restructuring accrual activities during the nine months ended September 30, 2023:


(in thousands)	Restructuring Accrual Balance
December 31, 2022	$	28,518
Restructuring charges	6,280
Asset sales and write-offs	(705)
Payments	(17,432)
Other, including foreign currency translation	(3)
September 30, 2023	$	16,658

NOTE 8—STOCKHOLDERS' EQUITY

Dividends

On February 16, 2023, the Company announced that our Board of Directors (“Board”) approved an increase of our regular quarterly cash dividend to $0.085 per share of the Company’s common stock. Our third quarter cash dividend of $0.085 per share was declared on August 10, 2023 and is payable on October 27, 2023 to shareholders of record on October 6, 2023. As a result, we recorded a dividend payable of $17.3 million on our condensed consolidated balance sheet as of September 30, 2023. Subsequent dividend declarations, if any, including the amounts and timing of future dividends, are subject to approval by the Board and will depend on future business conditions, financial conditions, results of operations and other factors.

Repurchases

On March 7, 2022, the Company announced that our Board authorized the Company to repurchase up to $250 million of its common stock. On October 24, 2022, our Board increased the authorization under this program to $750 million. This program has no time limit and does not obligate the Company to acquire any particular amount of shares of its common stock. During the three months ended September 30, 2023, we repurchased and cancelled 1,883,123 shares of common stock for a total of $68.1 million, including commissions and excise tax. During the nine months ended September 30, 2023, we repurchased and cancelled 5,069,102 shares of common stock for a total of $159.7 million, including commissions and excise tax.

NOTE 9—EARNINGS PER SHARE

A reconciliation of the number of shares used for the basic and diluted earnings per share calculation was as follows:


	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands, except per share data)	2023		2022		2023		2022
Net income attributable to ChampionX	$	77,711	$	23,068	$	237,040	$	87,112

Weighted-average number of shares outstanding	195,881		201,421		197,058		202,600
Dilutive effect of stock-based compensation	3,711		5,101		3,967		5,555
Total shares and dilutive securities	199,592		206,522		201,025		208,155

Earnings per share attributable to ChampionX:
Basic	$	0.40	$	0.11	$	1.20	$	0.43
Diluted	$	0.39	$	0.11	$	1.18	$	0.42

For all periods presented, the computation of diluted earnings per share excludes awards with an anti-dilutive impact. For the three and nine months ended September 30, 2023, the diluted shares include the dilutive impact of equity awards except for approximately 0.2 million and 0.4 million shares, respectively, that were excluded because their inclusion would be anti-dilutive. For the three and nine months ended September 30, 2022, the diluted shares include the dilutive impact of equity awards except for approximately 0.4 million shares and 0.4 million shares, respectively, that were excluded because their inclusion would be anti-dilutive.

NOTE 10—ACQUISITIONS AND DIVESTITURES

Acquisitions

Leak Surveys, Inc.

On February 23, 2022, we acquired the assets of Leak Surveys, Inc., a leader in optical gas imaging technology that provides aerial and ground-based emissions leak detection to the oil and gas industry. These assets have been included in our Production & Automation Technologies segment. Under the terms of the agreement, we paid an initial amount of $3.2 million, net of cash acquired, with an additional $0.5 million which was paid on the first anniversary of the closing date. We may also be required to make future payments of up to an additional $2.5 million, contingent on the future performance of the business. As part of our purchase price allocation, we recorded goodwill of $6.3 million in the first quarter of 2022. The pro forma effect of this acquisition on revenue and net income has been determined to be immaterial to our financial statements.

Divestitures

Due to the deteriorating business conditions in Russia following the Ukraine invasion and the resultant sanctions imposed by the United States, European Union, and United Kingdom, we initiated a plan to dispose of our operations in Russia (the “CT Russia Business”), which is included in our Production Chemical Technologies segment. As a result, the CT Russia Business met the criteria to be classified as held for sale during the second quarter of 2022 and we measured the carrying value of the disposal group to the lower of its carrying value or fair value less costs to sell.

We assess the fair value of the CT Russia Business (less any costs to sell) each reporting period that it remains classified as held for sale and report any subsequent changes as an adjustment to the carrying value of the asset or disposal group, as long as the new carrying value does not exceed the carrying value of the asset at the time it was initially classified as held for sale.

Due to the continued deterioration of the business environment, increasing trade regulations and sanctions and Russia’s imposition of an exit tax on divestments to facilitate exit from in-country operations, we assessed the fair value less cost to sell the business as of March 31, 2023 to be zero, resulting in a $13.0 million pre-tax impairment expense recorded during the three months ended March 31, 2023. There were no other changes in the nine month period ended September 30, 2023.

NOTE 11—FAIR VALUE MEASUREMENTS

Fair value is defined as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. A hierarchy has been established for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring the most observable inputs be used when available. The hierarchy is broken down into three levels:

Level 1- Inputs are quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities.

Level 2- Inputs include observable inputs other than quoted prices in active markets.

Level 3- Inputs are unobservable inputs for which there is little or no market data available.

The carrying amount and the estimated fair value for assets and liabilities measured on a recurring basis are as follows:


		Carrying Amount
(in thousands)	Measurement Level	September 30, 2023		December 31, 2022
Assets
Foreign currency forward contracts	Level 2	$	3,987	$	7,066
Interest rate swaps	Level 2	12,007		8,476
Total		$	15,994	$	15,542

Liabilities
Foreign currency forward contracts	Level 2	$	2,939	$	4,209
Interest rate swaps	Level 2	—		—
Total		$	2,939	$	4,209

The carrying value of foreign currency forward contracts is at fair value, which is determined based on foreign currency exchange rates as of the balance sheet date and is classified within Level 2. For purposes of fair value disclosure above, derivative values are presented gross. See Note 12—Derivatives and Hedging Transactions for further discussion of gross versus net presentation of the Company’s derivatives.

The carrying amounts of cash and cash equivalents, trade receivables, and accounts payable approximate their fair value due to their short-term nature.

The fair value of the 2022 Term Loan Facility is based on Level 2 quoted market prices for the same or similar debt instruments. The fair value of the 2022 Revolving Credit Facility approximates carrying value due to the variable interest rates charged on the borrowings, which reprice frequently (Level 2). The carrying amount and the estimated fair value of long-term debt, including current maturities, held by the Company were:


	September 30, 2023				December 31, 2022
(in thousands)	Carrying Amount		Fair Value		Carrying Amount		Fair Value
2022 Revolving Credit Facility	$	—	$	—	$	25,000	$	25,000
2022 Term Loan Facility	$	620,312	$	627,291	$	623,438	$	610,969

NOTE 12—DERIVATIVES AND HEDGING TRANSACTIONS

The Company uses foreign currency forward contracts to manage risks associated with foreign currency exchange rates. The Company also utilizes floating-to-fixed interest rate swap agreements as cash flow hedges on certain debt to mitigate interest rate risk. The Company does not hold derivative financial instruments of a speculative nature or for trading purposes. Derivative contracts are recorded as assets and liabilities on the balance sheet at fair value. We evaluated the interest rate swap hedge effectiveness and determined it to be perfectly effective. We evaluate foreign currency forward contracts hedge effectiveness at contract inception and thereafter on a quarterly basis. If a derivative is no longer expected to be effective, hedge accounting is discontinued. Changes in fair value are recognized immediately in earnings unless the derivative qualifies and is designated as a hedge. Changes in fair value attributable to changes in spot exchange rates for derivative contracts that have been designated as cash flow hedges are recognized in accumulated other comprehensive income (loss) (“AOCI”) and reclassified into earnings in the same period the hedged transaction affects earnings and are presented in the same income statement line as the earnings effect of the hedged item. The Company accounts for the interest rate swap agreements as a cash flow hedge, thus the effective portion of gains and losses resulting from changes in fair value are recognized in AOCI and are amortized to interest expense over the term of the respective debt. Cash flows from derivatives are classified in the statement of cash flows in the same category as the cash flows from the items subject to designated hedge or undesignated (economic) hedge relationships.

The Company is exposed to credit risk in the event of nonperformance of counterparties for foreign currency forward exchange contracts and interest rate swaps. We monitor our exposure to credit risk by using major banks and financial institutions as counterparties and monitoring their financial condition and credit profile. The Company does not anticipate nonperformance by any of these counterparties, and therefore, recording a valuation allowance against the Company’s derivative balance is not considered necessary.

Derivative Positions Summary

Certain of the Company’s derivative transactions are subject to master netting arrangements that allow the Company to settle with the same counterparties. These arrangements generally do not call for collateral and as of the applicable dates presented in the following table, no cash collateral had been received or pledged related to the underlying derivatives. We have elected to present our derivative balances on a gross basis on the condensed consolidated balance sheet.

The following table summarizes the gross fair value of the Company’s outstanding derivatives and the lines in which they are presented on the condensed consolidated balance sheet.


	Derivative Assets				Derivative Liabilities
(in thousands)	September 30, 2023		December 31, 2022		September 30, 2023		December 31, 2022
Prepaid expenses and other current assets	$	10,603	$	11,911	$	—	$	—
Other non-current assets	5,391		3,631		—		—
Accrued expenses and other current liabilities	—		—		2,939		4,209

	$	15,994	$	15,542	$	2,939	$	4,209

The following table summarizes the notional values of the Company’s outstanding derivatives:


(in thousands)	September 30, 2023		December 31, 2022
Notional value of foreign currency forward contracts and interest rate swaps	$	813,995	$	965,973

Cash Flow Hedges

The Company utilizes foreign currency forward contracts to hedge the effect of foreign currency exchange rate fluctuations on forecasted foreign currency transactions, primarily related to inventory purchases. These forward contracts are designated as cash flow hedges. The changes in fair value of these contracts attributable to changes in spot exchange rates are recorded in AOCI until the hedged items affect earnings, at which time the gain or loss is reclassified into the same line item in the condensed consolidated statements of income as the underlying exposure being hedged. The forward points are marked-to-market monthly and recognized in the same line item in the condensed consolidated statements of income as the underlying exposure being hedged.

Under interest rate swaps, we agree with other parties to exchange, at specified intervals, the difference between fixed-rate and floating-rate interest amounts calculated by reference to an agreed notional principal amount. Amounts reported in AOCI related to interest rate swaps at the time of settlement will be reclassified to interest expense, where we record the interest expense on the associated debt.

Derivatives Not Designated as Hedging Instruments

The Company also uses foreign currency forward contracts to offset its exposure to the change in value of certain foreign currency denominated assets and liabilities, primarily receivables and payables, which are remeasured at the end of each period. Although the contracts are effective economic hedges, they are not designated as accounting hedges. Therefore, changes in the value of these derivatives are recognized immediately in earnings, thereby offsetting the current earnings effect of the related foreign currency denominated assets and liabilities.

Effect of Derivative Instruments on Income

The loss of all derivative instruments recognized is summarized below:


	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Loss (gain) reclassified from AOCI to income on cash flow hedges:
Cost of goods and services	$	(190)	$	(837)	$	(2,113)	$	(884)
Interest expense	(1,645)		585		(3,904)		585
Loss on derivatives not designated as hedging instruments:
Other (income) expense, net	778		1,167		3,125		6,578
Total loss of derivative instruments	$	(1,057)	$	915	$	(2,892)	$	6,279

NOTE 13—INVENTORIES

Inventories consisted of the following:


(in thousands)	September 30, 2023		December 31, 2022
Raw materials	$	149,876	$	142,571
Work in progress	18,092		19,582
Finished goods	505,053		467,628
	673,021		629,781
Inventory reserve	(30,243)		(24,702)
LIFO adjustments (1)	(53,978)		(62,536)
Inventories, net	$	588,800	$	542,543

_______________________

(1) Represents the amount by which the current cost of LIFO inventories exceeded their carrying value.

NOTE 14—ACCOUNTS RECEIVABLE FACILITY

On June 28, 2022, we entered into an uncommitted accounts receivable purchase agreement (the “Accounts Receivable Facility”) with JPMorgan Chase Bank, N.A. as the purchaser. Transfers under the Accounts Receivable Facility are accounted for as sales of receivables, resulting in the receivables being derecognized from our condensed consolidated balance sheet. The purchaser assumes the credit risk at the time of sale and has the right at any time to assign or transfer (including as a participation interest) any of its rights under the purchased receivables to another bank or financial institution.

The amount available for sale under the Accounts Receivable Facility fluctuates over time based on the total amount of eligible receivables generated during the normal course of business. A maximum of $160.0 million in receivables may be sold and remain unpaid under the Accounts Receivable Facility at any time.

Accounts receivable sold were $543.4 million for the nine months ended September 30, 2023. The accounts receivable sold that remained outstanding as of September 30, 2023 was $112.9 million. During this period, cash receipts from the purchaser at the time of the sale were classified as operating activities in our condensed consolidated statement of cash flows. The difference between the carrying amount of the accounts receivable sold and the sum of the cash received is recorded as a loss on sale of receivables in other income (expense), net in our condensed consolidated statements of income. The loss on sale of accounts receivable was $1.9 million and $5.3 million for the three and nine months ended September 30, 2023, respectively.

NOTE 15—SUPPLY CHAIN FINANCE

We use a supply chain finance program in connection with the purchase of goods, which allows our suppliers to work directly with a third party to provide financing by purchasing their receivables earlier in the payment cycle. We maintain the same contractually agreed upon invoice terms prior to each supplier entering into the program. As of September 30, 2023, we had approximately $45.4 million outstanding under the program, which is included in accounts payable on our condensed consolidated balance sheet.

NOTE 16—CASH FLOW INFORMATION

Leased Asset Program

Our electrical submersible pumping leased asset program is reported in our Production & Automation Technologies segment. At the time of purchase, assets are recorded to inventory and are transferred to property, plant, and equipment when a customer contracts for an asset under our leased asset program. During the nine months ended September 30, 2023 and 2022, we transferred $77.2 million and $32.1 million, respectively, of inventory into property, plant, and equipment as a result of assets entering our leased asset program.

Expenditures for assets that are placed into our leased asset program expected to be recovered through sale are reported in leased assets in the operating section of our condensed consolidated statements of cash flows. All other capitalizable expenditures for assets that are placed into our leased asset program are classified as capital expenditures in the investing section of our condensed consolidated statements of cash flows.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This section provides our analysis of our financial performance, financial condition and significant trends that may affect our future performance. It should be read in conjunction with the condensed consolidated financial statements, and notes thereto, included elsewhere in this report. It contains forward-looking statements including, without limitation, statements relating to ChampionX’s plans, strategies, objectives, expectations and intentions that are made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are often identified by the words “believe,” “anticipate,” “expect,” “may,” “intend,” “foresee,” “guidance,” “estimate,” “potential,” “outlook,” “plan,” “should,” “would,” “could,” “target,” “forecast” and similar expressions, including the negative thereof. We undertake no obligation to publicly update, revise or correct any of our forward-looking statements after the date they are made, whether as a result of new information, future events or otherwise, except to the extent required under the federal securities laws. Readers are cautioned that such forward-looking statements should be read in conjunction with the disclosures under the heading “CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS.”

EXECUTIVE OVERVIEW AND BUSINESS OUTLOOK

We are a global leader in chemistry solutions, artificial lift systems, and highly engineered equipment and technologies that help companies drill for and produce oil and gas safely, efficiently, and sustainably around the world. Our expertise, innovative products, and digital technologies provide enhanced oil and gas production, transportation, and real-time emissions monitoring throughout the lifecycle of a well. Our business is organized into four reportable segments: Production Chemical Technologies, Production & Automation Technologies, Drilling Technologies, and Reservoir Chemical Technologies. We refer to the Production Chemical Technologies segment and Reservoir Chemical Technologies segment together as the Chemical Technologies business.

Recent Events

Russia’s invasion of Ukraine and the related sanctions imposed present economic risk to companies that engage in business within, or have economic ties to, Russia. Our Russia operations (the “CT Russia Business”) are fully contained within the country and include a manufacturing plant and related inventory, service operations, an established customer base and local employees, and has the ability to operate as a standalone business under the brand, Master Chemicals. During the second quarter of 2022, we initiated a plan to dispose of the CT Russia Business. As a result, the CT Russia Business met the criteria to be reported as held for sale and, therefore, was reflected in our condensed consolidated balance sheet at the lower of its carrying value or its fair value less costs to sell. Due to the continued economic pressure and sanctions imposed by the United States (“U.S.”), European Union, and United Kingdom, increasing costs to sell and increased trade regulations and political instability in Russia, we assessed the fair value less cost to sell the business as of March 31, 2023 to be zero, resulting in a $13.0 million pre-tax impairment expense recorded during the three months ended March 31, 2023. Since March 31, 2023, we no longer recognize any revenues or expenses associated with the CT Russia Business. Prior to such date, the revenues, net income and total assets of the CT Russia Business represented less than 2% of our consolidated results of operations.

We conduct operations around the world in a number of different currencies, and fluctuations in currency exchange rates or the inability to exchange or repatriate foreign currencies could materially impact our business. The impact of foreign currency fluctuations on our results of operations has historically not been material; however, over the past year the Argentine peso devalued approximately 50%. We have operated in Argentina for over 40 years, generating annual sales of approximately $100.0 million during the last two years. Historically, we have been able to repatriate sufficient currency to maintain a minimal foreign exchange exposure in country. However, in 2023, the Argentine government has taken numerous actions to delay payments, slow the importation of goods and delay the repatriation of funds to parent entities outside Argentina. Due to the peso devaluation, primarily following the national primary election round, we recognized foreign exchange losses of approximately $7.2 million during the three months ended September 30, 2023. As we monitor the recent actions on imports, payments, and repatriation, we have taken commercial actions to address the situation; specifically, curtailing new business, renegotiating contracts with customers, and exploring other alternatives to reduce our foreign exchange exposure. As of September 30, 2023, we maintain approximately $18.0 million United States dollar equivalent of foreign exchange exposure in Argentine pesos.

Business Environment

We monitor macro-economic conditions and industry-specific drivers and key risk factors affecting our business segments as we formulate our strategic plans and make decisions related to allocating capital and human resources. Our business segments

provide a broad range of technologies and products to support oil and gas production, exploration and development, and the midstream sector. As a result, we are substantially dependent upon global oil production levels, as well as new investment activity levels in the oil and gas and midstream sectors. Demand for our products, technologies and services is impacted by overall global demand for oil and gas, ongoing depletion rates of existing oil and gas wells, and our customers’ willingness to invest in the exploration for and development of new oil and gas resources. Our customers determine their operating and capital budgets based on current and expected future crude oil and natural gas prices, U.S. and worldwide rig count, U.S. well completions and expected industry cost levels, among other factors. Crude oil and natural gas prices are impacted by supply and demand, which are influenced by geopolitical, macroeconomic, and local events, and have historically been subject to substantial volatility and cyclicality. Rig count, footage drilled, and exploration and production investment by oil and gas operators have often been used as leading indicators for the level of drilling and development activity and future production levels in the oil and gas sector.

Market Conditions and Outlook

In recent years, oil prices have remained volatile due to various factors such as the impact of the COVID-19 pandemic, oil supply constraints, geopolitical instability, extended periods of inflation, and concerns of a global recession. During the third quarter of 2023, following four consecutive quarterly declines, oil prices began to increase due to short-term supply concerns. Rig counts in the U.S. have continued to decline. Short-term demand has begun to outpace supply after the announced OPEC+ production cuts through the remainder of the year; however, this trend is expected to moderate in the first half of 2024, particularly due to non-OPEC+ oil production growth and the possibility of an end to voluntary production cuts by OPEC+ countries. According to the U.S. Energy Information Administration, global demand is expected to continue to increase, albeit moderately, through the remainder of the year. Limits on the pace of supply growth, coupled with stable demand, are expected to cause oil prices to remain elevated in the short term.

Inflation rates have begun to moderate. Nonetheless, we continue to actively monitor market trends specifically related to the sourcing of raw materials. We also continue to work diligently to ensure selling prices offset the impact of raw material, labor, and logistics-related inflation on our businesses. Our productivity and continuous improvement initiatives are focused on delivering expanding profit margins in all our businesses.

CRITICAL ACCOUNTING ESTIMATES

Refer to our “Critical Accounting Estimates” included in Part II, Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2022 for a discussion of our critical accounting estimates.

CONSOLIDATED RESULTS OF OPERATIONS


	Three Months Ended
	September 30,		June 30,		Variance
(in thousands)	2023		2023		$
Revenue	$	939,783	$	926,600	$	13,183
Cost of goods and services	647,923		644,394		3,529
Gross profit	291,860		282,206		9,654
Selling, general and administrative expense	162,317		162,484		(167)


Interest expense, net	13,744		14,544		(800)
Other expense (income), net	5,998		(3,104)		9,102
Income before income taxes	109,801		108,282		1,519
Provision for income taxes	29,009		11,656		17,353
Net income	80,792		96,626		(15,834)
Net income attributable to noncontrolling interest	3,081		829		2,252
Net income attributable to ChampionX	$	77,711	$	95,797	$	(18,086)

Revenue. Revenue increased $13.2 million, or 1%, sequentially, primarily due to the increase in our Production Chemical Technologies segment.

Gross profit. Gross profit increased $9.7 million, or 3%, sequentially mainly due to improvements in our cost of goods sold and continued productivity gains.

Selling, general and administrative expense. Selling, general and administrative expense was flat sequentially.

Interest expense, net. Interest expense was flat sequentially.

Other expense (income), net. Other expense, net was $6.0 million for the three months ended September 30, 2023, compared to other income, net of $3.1 million in the prior quarter. This change was primarily due to the impact of varying foreign currency exchange losses during the quarter, principally a $7.2 million loss recognized in 2023 due to the devaluation of the Argentine peso.

Provision for income taxes. Our provision for income taxes reflected effective tax rates (“ETR”) of 26.4% and 10.8% for the three months ended September 30, 2023 and June 30, 2023, respectively. The increase to the ETR for the quarter ending September 30, 2023 was primarily driven by discrete benefits due to a return to provision adjustment in Argentina and an update to a prior year estimate in the U.S. during the three months ended June 30, 2023.


	Nine Months Ended
	September 30,				Variance
(in thousands)	2023		2022		$
Revenue	$	2,814,730	$	2,820,093	$	(5,363)
Cost of goods and services	1,957,309		2,204,052		(246,743)
Gross profit	857,421		616,041		241,380
Selling, general and administrative expense	485,617		445,447		40,170

Loss on disposal group	12,965		16,515		(3,550)
Interest expense, net	40,754		33,582		7,172
Other expense, net	8,189		10,968		(2,779)
Income before income taxes	309,896		109,529		200,367
Provision for income taxes	69,334		19,235		50,099
Net income	240,562		90,294		150,268
Net income attributable to noncontrolling interest	3,522		3,182		340
Net income attributable to ChampionX	$	237,040	$	87,112	149,928

Revenue. Revenue remained essentially flat for the nine months ended September 30, 2023 compared to prior year. Revenue within our Production Chemical Technologies and Production & Automation Technologies reportable segments posted year over year increases, driven by incremental volumes and global pricing, but were largely offset by a reduction in revenue within our Reservoir Chemical Technologies segment due to the exit of our friction reducer product line in the prior year, decrease in our Production Chemical Technologies segment associated with our decision to exit our CT Russia Business, and a decline in revenue derived from the Cross Supply and Product Transfer Agreement with Ecolab Inc. (“Ecolab”). We also experienced a decrease in revenue within our Drilling Technologies segment driven by lower U.S. rig count and customer activity.

Gross profit. Gross profit increased $241.4 million, or 39%, for the nine months ended September 30, 2023 compared to prior year, mainly due to the incremental volumes and pricing noted above as well as improved margins from the exit of the friction reducer product line in our Reservoir Chemical Technologies segment.

Selling, general and administrative expense. Selling, general and administrative expense increased $40.2 million, or 9%, for the nine months ended September 30, 2023 compared to prior year, primarily due to an increase in labor costs and general inflation.

Loss on disposal group. Amounts for each period represent the loss incurred to write down the assets within our CT Russia Business to its recoverable value, which as of March 31, 2023 was zero.

Interest expense, net. Interest expense, net increased $7.2 million, or 21%, for the nine months ended September 30, 2023 compared to prior year primarily due to an increase in interest rates.

Other expense, net. Other expense, net decreased $2.8 million, primarily due to the loss on debt extinguishment recognized in the prior year.

Provision for income taxes. The ETR for the first nine months of 2023 and 2022 were 22.4% and 17.6%, respectively. The ETR for the first nine months of 2023 was negatively impacted primarily by withholding taxes. The ETR for the first nine months of 2022 was positively impacted by the release of the valuation allowance on our operations in Angola, a charge incurred on the CT Russia Business upon classifying to held for sale, and return to provision adjustments in several foreign jurisdictions.

SEGMENT RESULTS OF OPERATIONS


	Three Months Ended
	September 30,		June 30,		Variance
(in thousands)	2023		2023		$
Segment revenue:
Production Chemical Technologies	$	604,254	$	574,302	$	29,952
Production & Automation Technologies	256,148		254,156		1,992
Drilling Technologies	54,869		57,324		(2,455)
Reservoir Chemical Technologies	25,093		23,853		1,240
Corporate and other(1)	(581)		16,965		(17,546)
Total revenue	$	939,783	$	926,600	$	13,183

Segment operating profit (loss):
Production Chemical Technologies	$	94,560	$	87,163	$	7,397
Production & Automation Technologies	28,299		33,208		(4,909)
Drilling Technologies	12,255		12,660		(405)
Reservoir Chemical Technologies	2,461		2,186		275
Total segment operating profit	137,575		135,217		2,358
Corporate expense and other(1)	14,030		12,391		1,639
Interest expense, net	13,744		14,544		(800)
Income before income taxes	$	109,801	$	108,282	$	1,519

_______________________

(1) Corporate and other includes costs not directly attributable or allocated to our reporting segments such as overhead and other costs pertaining to corporate executive management and other administrative functions, and the results attributable to our noncontrolling interest. Additionally, the sales and expenses related to the Cross Supply and Product Transfer Agreement with Ecolab were included within Corporate and other from June 3, 2020, the date we acquired the Chemical Technologies business from Ecolab, through June 30, 2023. Beginning July 1, 2023, these sales and expenses are recognized in the Production Chemical Technologies segment.

Production Chemical Technologies

Revenue. Production Chemical Technologies revenue, including sales to Ecolab that were previously included in Corporate and other increased $30.0 million, or 5%, sequentially, mainly due to higher demand both in North America and internationally.

Operating profit. Production Chemical Technologies operating profit increased $7.4 million, or 8%, in the third quarter of 2023 compared to the prior quarter due to higher sales volumes, offset by $7.2 million of foreign exchange losses related to the devaluation of the Argentine peso during the third quarter.

Production & Automation Technologies

Revenue. Production & Automation Technologies revenue remained essentially flat.

Operating profit. Production & Automation Technologies operating profit decreased by $4.9 million, or 15%, in the third quarter of 2023 compared to the prior quarter due to unfavorable changes in product mix.

Drilling Technologies

Revenue. Drilling Technologies revenue decreased $2.5 million, or 4%, in the third quarter of 2023 compared to the prior quarter primarily due to lower U.S. rig counts and lower customer activity.

Operating profit. Drilling Technologies operating profit decreased $0.4 million, or 3%, in the third quarter of 2023 compared to the prior quarter due to lower revenues.

Reservoir Chemical Technologies

Revenue. Reservoir Chemical Technologies revenue increased $1.2 million, or 5%, in the third quarter of 2023 compared to the prior quarter primarily due to higher volumes in the U.S. and Latin America.

Operating profit. Reservoir Chemical Technologies operating profit increased $0.3 million, or 13%, in the third quarter of 2023 compared to the prior quarter as the segment continues to benefit from cost reduction initiatives associated with the exit of certain product lines.


	Nine Months Ended September 30,				Variance
(in thousands)	2023		2022		$
Segment revenue:
Production Chemical Technologies	$	1,770,240	$	1,710,987	$	59,253
Production & Automation Technologies	761,852		710,465		51,387
Drilling Technologies	168,900		175,682		(6,782)
Reservoir Chemical Technologies	74,752		119,499		(44,747)
Corporate(1)	38,986		103,460		(64,474)
Total revenue	$	2,814,730	$	2,820,093	$	(5,363)

Segment operating profit (loss):
Production Chemical Technologies	$	248,037	$	143,518	$	104,519
Production & Automation Technologies	96,299		70,845		25,454
Drilling Technologies	36,802		45,119		(8,317)
Reservoir Chemical Technologies	6,634		(73,327)		79,961
Total segment operating profit	387,772		186,155		201,617
Corporate expense and other(1)	37,122		43,044		(5,922)
Interest expense, net	40,754		33,582		7,172
Income before income taxes	$	309,896	$	109,529	$	200,367

_______________________

(1) Corporate and other includes costs not directly attributable or allocated to our reporting segments such as overhead and other costs pertaining to corporate executive management and other administrative functions, and the results attributable to our noncontrolling interest. Additionally, the sales and expenses related to the Cross Supply and Product Transfer Agreement with Ecolab were included within Corporate and other from June 3, 2020, the date we acquired the Chemical Technologies business from Ecolab, through June 30, 2023. Beginning July 1, 2023, these sales and expenses are recognized in the Production Chemical Technologies segment.

Production Chemical Technologies

Revenue. Production Chemical Technologies revenue increased $59.3 million, or 3%, as compared to the prior year, mainly due to market share expansion and price increases to offset inflation.

Operating profit. Operating profit increased $104.5 million, or 73%, compared to the prior year, primarily due to the incremental revenues noted above, continued productivity initiatives, and lower expenses in 2023 related to restructuring expenses and charges associated with the CT Russia Business in the prior year’s period.

Production & Automation Technologies

Revenue. Revenue increased $51.4 million, or 7%, as compared to the prior year, primarily due to higher volumes across our product offerings in North America and favorable mix and productivity gains.

Operating profit. Operating profit increased $25.5 million, or 36%, compared to the prior year primarily due to higher volumes and price as noted above, improvements in raw materials and freight costs, and productivity initiatives.

Drilling Technologies

Revenue. Revenue decreased $6.8 million, or 4%, as compared to the prior year due to lower U.S. rig count and customers restocking inventory during the 2022 period.

Operating profit. Operating profit decreased $8.3 million, or 18%, compared to the prior year primarily due to decreased revenues, change in product mix and the impact of inflation and certain operating cost increases.

Reservoir Chemical Technologies

Revenue. Revenue decreased $44.7 million, or 37%, compared to the prior year primarily due to the impact of the exit of our friction reducer product line in the prior year.

Operating profit. Operating profit increased $80.0 million compared to the prior year, due to the positive impact associated with exiting certain unprofitable product lines and a $68.7 million reduction in restructuring charges compared to 2022.

CAPITAL RESOURCES AND LIQUIDITY

Overview

Our primary source of cash is from operating activities. We have historically generated, and expect to continue to generate, positive cash flow from operations. Cash generated from operations is generally allocated to working capital requirements, investments to support profitable revenue growth and maintain our facilities and systems, acquisitions that create value through add-on capabilities that broaden our existing businesses and support our growth strategy, as well as share repurchases, dividend payments to stockholders, and debt repayments to reduce our leverage.

On June 7, 2022, we entered into a restated credit agreement, which provides for (i) a $625.0 million seven-year senior secured term loan B facility (the “2022 Term Loan Facility”) and (ii) a five-year senior secured revolving credit facility in an aggregate principal amount of $700.0 million, of which $100.0 million is available for the issuance of letters of credit (the “2022 Revolving Credit Facility” and, together with the 2022 Term Loan Facility, the “Senior Secured Credit Facility”). The full amount of the 2022 Term Loan Facility was funded, and $135.0 million of the 2022 Revolving Credit Facility was drawn, on June 7, 2022.

On September 29, 2023, we amended the 2022 Term Loan Facility to reprice the Company’s $620.3 million of existing term loans, in connection with which new term loans in the same amount were issued. The new term loans bear interest at a per annum rate of (i) an adjusted SOFR Rate plus 2.75% per annum or (ii) a base rate plus 1.75%. The new term loans may be prepaid at any time without penalty, other than a 1.00% premium if the loans are repriced at any time prior to March 30, 2024 and subject to the payment of customary breakage costs in the case of the SOFR rate loans. All other material terms of the Senior Secured Credit Facility remain unchanged.

At September 30, 2023, we had cash and cash equivalents of $285.0 million compared to $250.2 million at December 31, 2022, primarily for working capital and operational purposes. At September 30, 2023, we had total liquidity of $954.3 million, comprised of $285.0 million of cash and $669.3 million of available capacity on the 2022 Revolving Credit Facility, which expires in June 2027.

At September 30, 2023, we had a long-term debt balance of $594.9 million, net of the current portion of long-term debt of $6.3 million, consisting of the 2022 Term Loan Facility with a principal amount of $620.3 million.

Outlook

We expect to support business requirements with cash generated from operations and, if necessary, through the use of the 2022 Revolving Credit Facility. Volatility in credit, equity and commodity markets can create uncertainty for our businesses. However, the Company believes, based on our current financial condition and current expectations of future market conditions, that we will meet our short- and long-term needs with a combination of cash on hand, cash generated from operations, the 2022 Revolving Credit Facility and access to capital markets.

On February 16, 2023, the Company announced that our Board of Directors (“Board”) approved an increase of our regular quarterly cash dividend to $0.085 per share of the Company’s common stock. Our third quarter cash dividend of $0.085 per share was declared on August 10, 2023 and is payable on October 27, 2023 to shareholders of record on October 6, 2023. Subsequent dividend declarations, if any, including the amounts and timing of future dividends, are subject to approval by our Board and will depend on future business conditions, financial conditions, results of operations and other factors.

On March 7, 2022, the Company announced that our Board approved a new $250 million share repurchase program (“2022 Share Repurchase Program”). On October 24, 2022, our Board increased the authorization under this program to $750 million. Under the 2022 Share Repurchase Program, shares of the Company’s common stock may be repurchased periodically, including in the open market or privately negotiated transactions. We expect to fund share repurchases from cash generated from operations. During the three months ended September 30, 2023, we repurchased and cancelled 1,883,123 shares of common stock for a total of $68.1 million, including commissions and excise tax. The actual timing, manner, number, and value of shares repurchased under the program will depend on a number of factors, including the availability of excess free cash, the market price of the Company’s common stock, general market and economic conditions, applicable requirements, and other business considerations.

In 2023, we expect to fund our capital expenditures and reduce outstanding debt through earnings and working capital improvements. We project 2023 capital expenditures of 3.0% to 3.5% of revenue inclusive of capital investments for our electric submersible pump leased assets.

Information related to guarantees is incorporated herein by reference from Note 6—Commitments and Contingencies to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.

Cash Flows


	Nine Months Ended September 30,
(in thousands)	2023		2022
Cash from operating activities	$	371,318	$	218,267
Cash used in investing activities	(98,637)		(61,526)
Cash used in financing activities	(236,548)		(215,201)
Effect of exchange rate changes on cash and cash equivalents and restricted cash	(1,314)		(5,746)
Net increase (decrease) in cash and cash equivalents and restricted cash	$	34,819	$	(64,206)

Operating Activities

Cash provided by operating activities during the nine months ended September 30, 2023 was $371.3 million as compared to $218.3 million for the nine months ended September 30, 2022. The change was primarily driven by the increase in net income of $150.3 million, partially offset by the use of cash for working capital items. Changes in working capital items used cash of $84.4 million during the nine months ended September 30, 2023 compared to cash used of $68.4 million during nine months ended September 30, 2022. The change in working capital items primarily related to decreases in accounts payable and inventory and strong cash collections during the 2023 period.

Investing Activities

Cash used in investing activities was $98.6 million for the nine months ended September 30, 2023, and was primarily comprised of capital expenditures of $111.0 million, partially offset by $12.3 million of cash proceeds from the sale of fixed assets.

Cash used in investing activities was $61.5 million for the nine months ended September 30, 2022, and was primarily comprised of capital expenditures of $74.8 million and acquisitions, net of cash acquired, of $3.2 million. This was partially offset by $16.4 million of cash proceeds from the sale of fixed assets primarily due to the sale of facilities within our Production & Automation Technologies segment.

Financing Activities

Cash used in financing activities of $236.5 million for the nine months ended September 30, 2023 was primarily the result of repurchases of our common stock of $159.7 million, dividends paid of $48.3 million, net repayments totaling $28.1 million on long-term debt, payments related to taxes withheld on stock-based compensation of $9.7 million, payments of finance lease obligations of $7.1 million, and distributions to non-controlling interests of $2.3 million. This was partially offset by $14.0 million of proceeds expected to be remitted under the Accounts Receivable Facility (as defined below) and $5.8 million in cash proceeds from the exercise of stock options.

Cash used in financing activities of $215.2 million for the nine months ended September 30, 2022 was primarily the result of net repayments totaling $76.3 million on long-term debt as part of our refinancing, repurchases of our common stock of $100.1 million, dividends paid of $30.5 million, payment of debt issuance costs of $8.0 million, payments related to taxes withheld on stock-based compensation of $3.6 million, and payments totaling $4.5 million for finance lease obligations. This was partially offset by $3.7 million in cash proceeds from the exercise of stock options.

Revolving Credit Facility

A summary of the 2022 Revolving Credit Facility at September 30, 2023 was as follows:


(in millions) Description	Amount		Debt Outstanding		Letters of Credit		Unused Capacity		Maturity
Five-year revolving credit facility	$	700.0	$	—	$	30.7	$	669.3	June 2027

Additionally, we have letters of credit outside of the 2022 Revolving Credit Facility totaling approximately $2.4 million. As of September 30, 2023, we were in compliance with all restrictive covenants under the 2022 Revolving Credit Facility.

Accounts Receivable Facility

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We may be exposed to certain market risks arising from the use of financial instruments in the ordinary course of business. For quantitative and qualitative disclosures about market risk, see Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk,” in our Annual Report on Form 10-K for the year ended December 31, 2022. Our exposure to market risk has not materially changed since December 31, 2022.

ITEM 4. CONTROLS AND PROCEDURES

Our management, with the participation of our principal executive officer and principal financial officer, carried out an evaluation, pursuant to Rule 13a-15(b) of the Exchange Act, of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of September 30, 2023.

There were no changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2023, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II — OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We are involved in various pending or potential legal actions in the ordinary course of our business. Management is unable to predict the ultimate outcome of these actions because of the inherent uncertainty of litigation. However, management believes the most probable, ultimate resolution of these matters will not have a material adverse effect on our condensed consolidated financial position, results of operations or cash flows. See Note 6—Commitments and Contingencies to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.

ITEM 1A. RISK FACTORS

Except as set forth below, there have not been material changes from the risk factors previously disclosed in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2022.

Risks Related to Our Business

Our operations are subject to the risk of manufacturing disruptions, and hazards common to manufacturing and supplying chemical products, the occurrence of which could materially and adversely affect our business.

As a manufacturer and supplier of chemical products, we face potential hazards common in such operations such as fires, explosions, and chemical spills, releases or discharges, either in liquid or gaseous form, during production, transportation, storage or use. Such an occurrence could result in loss of life, severe injury, environmental contamination, and disruption for, and damage to, our manufacturing facilities, customers, communities, and other stakeholders, as well as significant remediation costs and other liabilities that may exceed the coverage provided by our insurance policies. Accordingly, such hazards could have a material adverse effect on our business, financial condition, results of operations and cash flows.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES, USE OF PROCEEDS, AND ISSUER PURCHASES OF EQUITY SECURITIES

The following table contains information about our purchases of our common stock during the three months ended September 30, 2023.


Period	Total Number of Shares Purchased	Average Price Paid Per Share (1)		Total Number of Shares Purchased as Part of a Publicly Announced Program (2)	Maximum Dollar Value of Shares that May Yet Be Purchased Under the Program (2)
July 1-31, 2023	84,176	$	35.60	84,176	$	476,331,566
August 1-31, 2023	1,423,064	$	35.53	1,423,064	$	425,767,169
September 1-30, 2023	375,883	$	36.90	375,883	$	411,896,385
Total	1,883,123	$	35.81	1,883,123

_______________________

(1)Excluding fees, commissions, and expenses associated with the share repurchases.

(2)On March 7, 2022, the Company announced that our Board authorized the Company to repurchase up to $250 million of its common stock. On October 24, 2022, our Board increased the authorization under this program to $750 million. This program has no time limit and does not obligate the Company to acquire any particular amount of shares of its common stock.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

Iran Threat Reduction and Syria Human Rights Act of 2012

Under the Iran Threat Reduction and Syria Human Rights Act of 2012, which added Section 13(r) of the Exchange Act, the Company is required to disclose in its periodic reports if it or any of its affiliates knowingly engaged in certain activities, transactions or dealings relating to Iran or with entities or individuals designated pursuant to certain Executive Orders. Disclosure is required even where the activities are conducted outside the U.S. by non-U.S. affiliates in compliance with applicable law, and even if the activities are not covered or prohibited by U.S. law.

As authorized by the U.S. Treasury’s Office of Foreign Assets Control (“OFAC”), a non-U.S. subsidiary of the Company which is part of our Chemical Technologies business completed sales of products used for process and water treatment applications in upstream oil and gas production related to the operation of and production from the Rhum gas field off the Scottish coast (“Rhum”) totaling $196,220 during the period from July 1, 2023 to September 30, 2023. The net profit before taxes associated with these sales for each period were nominal. Rhum is jointly owned by Serica Energy plc and Iranian Oil Company (U.K.) Limited. Our non-U.S. subsidiary intends to continue the Rhum-related activities, consistent with a specific license obtained from OFAC by its customers, and such activities may require additional disclosure pursuant to the above mentioned statute.

Insider Trading Arrangements and Policies

During the three months ended September 30, 2023, none of the Company’s directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) informed us of the adoption or termination of a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K, except as described in the table below:

Name & Title

Date Adopted

Character of Trading Arrangement

(1)

Aggregate Number of Shares of Common Stock to be Purchased or Sold Pursuant to Trading Arrangement

Duration

(2)

Other Material Terms

Date Terminated

Deric Bryant, Chief Operating Officer and President, Chemical Technologies

August 15, 2023

Rule 10b5-1 Trading Arrangement

Up to 384,596 shares to be sold

December 31, 2024

N/A

William R. O' Dell, President, Oilfield and Specialty Performance

August 10, 2023

Rule 10b5-1 Trading Arrangement

Up to 27,178 shares to be sold

August 30, 2024

N/A

_______________________

(1)Each trading arrangement marked as a “Rule 10b5-1 Trading Arrangement” is intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act, (the “Rule”).

(2)Each trading arrangement permits transactions through and including the earlier to occur of (i) the completion of all sales of shares subject to the arrangement, (ii) the date listed in the “Duration” column, or (iii) the occurrence of such other termination event as specified in the arrangement. Each trading arrangement marked as a “Rule 10b5-1 Trading Arrangement” only permits transactions upon expiration of the applicable mandatory cooling-off period under the Rule.

ITEM 6. EXHIBITS

Incorporated by Reference

Exhibit
No.

Exhibit Description

Form

Exhibit No.

Filing Date

3.1

Second Amended and Restated Certificate of Incorporation of the Company.

8-K

3.1

May 11, 2023

3.2

Amended and Restated By-Laws of the Company.

8-K

3.2

May 11, 2023

10.1

Amendment No. 1 to Amended and Restated Credit Agreement, dated September 29, 2023, by and among the Company, as borrower, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent

8-K

10.1

October 3, 2023

31.1*

Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended.

31.2*

Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended.

32.1**

Certification of Chief Executive Officer Under Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. 1350.

32.2**

Certification of Chief Financial Officer Under Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. 1350.

101.INS*

XBRL Instance Document

101.SCH*

XBRL Taxonomy Extension Schema Document

101.CAL*

XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF*

XBRL Taxonomy Extension Definition Linkbase Document

101.LAB*

XBRL Taxonomy Extension Label Linkbase Document

101.PRE*

XBRL Taxonomy Extension Presentation Linkbase Document

104*

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

* Filed herewith

** Furnished herewith

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


CHAMPIONX CORPORATION
(Registrant)

/s/ ANTOINE MARCOS
Antoine Marcos
Vice President, Corporate Controller and Chief Accounting Officer
(Principal Accounting Officer and a Duly Authorized Officer)

Date:			October 25, 2023

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULE 13A-14(A) AND RULE 15D-14(A)

OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

I, Sivasankaran Somasundaram, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of ChampionX Corporation (the “registrant”);

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:

October 25, 2023

/s/ SIVASANKARAN SOMASUNDARAM

Sivasankaran Somasundaram

President and Chief Executive Officer

(Principal Executive Officer)

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13A-14(A) AND RULE 15D-14(A)

OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

I, Kenneth M. Fisher, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of ChampionX Corporation (the “registrant”);

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:

October 25, 2023

/s/ KENNETH M. FISHER

Kenneth M. Fisher

Executive Vice President and
Chief Financial Officer

(Principal Financial Officer)

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

UNDER SECTION 906 OF THE SARBANES-OXLEY

ACT OF 2002, 18 U.S.C. SECTION 1350

I, Sivasankaran Somasundaram, President and Chief Executive Officer of ChampionX Corporation (the “Company”), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(a) The Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2023, as filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(b) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:

October 25, 2023

/s/ SIVASANKARAN SOMASUNDARAM

Sivasankaran Somasundaram

President and Chief Executive Officer

(Principal Executive Officer)

Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

UNDER SECTION 906 OF THE SARBANES-OXLEY

ACT OF 2002, 18 U.S.C. SECTION 1350

I, Kenneth M. Fisher, Executive Vice President and Chief Financial Officer of ChampionX Corporation (the “Company”), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(b) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:

October 25, 2023

/s/ KENNETH M. FISHER

Kenneth M. Fisher

Executive Vice President and
Chief Financial Officer

(Principal Financial Officer)

Cover Page - shares shares in Millions	9 Months Ended
Cover Page - shares shares in Millions	Sep. 30, 2023	Oct. 19, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2023
Document Transition Report	false
Entity File Number	001-38441
Entity Registrant Name	ChampionX Corp
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	82-3066826
Entity Address, Address Line One	2445 Technology Forest Blvd,
Entity Address, Address Line Two	Building 4, 12th Floor
Entity Address, City or Town	The Woodlands,
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	77381
City Area Code	(281)
Local Phone Number	403-5772
Security 12b Title	Common stock, $0.01 par value
Trading Symbol	CHX
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		194.8
Entity Central Index Key	0001723089
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Amendment Flag	false

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Revenue:
Lease and other revenue	$ 25,275	$ 22,807	$ 71,893	$ 64,881
Total revenue	939,783	1,021,561	2,814,730	2,820,093
Cost of goods and services	647,923	825,018	1,957,309	2,204,052
Gross profit	291,860	196,543	857,421	616,041
Costs and expenses:
Selling, general and administrative expense	162,317	153,736	485,617	445,447
Loss (gain) on disposal group	0	(6,409)	12,965	16,515
Interest expense, net	13,744	11,454	40,754	33,582
Other expense, net	5,998	291	8,189	10,968
Income before income taxes	109,801	37,471	309,896	109,529
Provision for income taxes	29,009	14,246	69,334	19,235
Net income	80,792	23,225	240,562	90,294
Net income attributable to noncontrolling interest	3,081	157	3,522	3,182
Net income attributable to ChampionX	$ 77,711	$ 23,068	$ 237,040	$ 87,112
Earnings per share attributable to ChampionX:
Basic (in dollars per share)	$ 0.40	$ 0.11	$ 1.20	$ 0.43
Diluted (in dollars per share)	$ 0.39	$ 0.11	$ 1.18	$ 0.42
Weighted-average shares outstanding:
Basic (in shares)	195,881	201,421	197,058	202,600
Diluted (in shares)	199,592	206,522	201,025	208,155
Product revenue
Revenue:
Revenue	$ 827,659	$ 897,156	$ 2,474,098	$ 2,455,377
Service revenue
Revenue:
Revenue	$ 86,849	$ 101,598	$ 268,739	$ 299,835

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ 80,792	$ 23,225	$ 240,562	$ 90,294
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	(13,144)	(47,067)	(14,800)	(27,463)
Cash flow hedges	6,164	16,310	1,706	11,608
Defined pension and other post-retirement benefits adjustments, net	59	68	10	207
Other comprehensive loss	(6,921)	(30,689)	(13,084)	(15,648)
Comprehensive income (loss)	73,871	(7,464)	227,478	74,646
Less: Comprehensive income attributable to noncontrolling interest	3,081	157	3,522	3,182
Comprehensive income (loss) attributable to ChampionX	$ 70,790	$ (7,621)	$ 223,956	$ 71,464

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Current Assets:
Cash and cash equivalents	$ 285,006	$ 250,187
Receivables, net of allowances of $6,148 in 2023 and $5,148 in 2022	520,106	601,061
Inventories, net	588,800	542,543
Assets held for sale	9,959	29,334
Prepaid expenses and other current assets	81,825	75,456
Total current assets	1,485,696	1,498,581
Property, plant, and equipment, net of accumulated depreciation of $751,939 in 2023 and $693,226 in 2022	763,559	734,810
Goodwill	666,108	679,488
Intangible assets, net	256,376	305,010
Operating lease right-of-use assets	75,924	92,928
Other non-current assets	63,541	76,666
Total assets	3,311,204	3,387,483
Current Liabilities:
Current portion of long-term debt	6,250	6,250
Accounts payable	500,021	469,566
Accrued compensation and employee benefits	90,772	102,750
Current portion of operating lease liabilities	24,586	28,838
Accrued distributor fees	38,531	102,034
Liabilities held for sale	0	7,186
Accrued expenses and other current liabilities	133,716	142,352
Total current liabilities	793,876	858,976
Long-term debt	594,943	621,702
Deferred income taxes	77,457	94,235
Operating lease liabilities	46,162	59,686
Other long-term liabilities	92,638	75,669
Total liabilities	1,605,076	1,710,268
Stockholders’ equity:
Common stock (2.5 billion shares authorized, $0.01 par value) 195.0 million shares and 198.5 million shares issued and outstanding in 2023 and 2022, respectively	1,950	1,985
Capital in excess of par value of common stock	2,204,974	2,249,698
Accumulated deficit	(442,831)	(527,603)
Accumulated other comprehensive loss	(42,614)	(29,530)
ChampionX stockholders’ equity	1,721,479	1,694,550
Noncontrolling interest	(15,351)	(17,335)
Total equity	1,706,128	1,677,215
Total liabilities and equity	$ 3,311,204	$ 3,387,483

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - USD ($) $ in Thousands, shares in Millions	Sep. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Receivables, allowances	$ 6,148	$ 5,148
Accumulated depreciation on property, plant and equipment	$ 751,939	$ 693,226
Common stock, shares authorized (in shares)	2,500.0	2,500.0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares issued (in shares)	195.0	198.5
Common stock, shares outstanding (in shares)	195.0	198.5

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Capital in Excess of Par Value	Accum. Deficit	Accum. Other Comp. Loss	Non-controlling Interest
Beginning balance (in shares) at Dec. 31, 2021		202,866,000
Beginning balance at Dec. 31, 2021	$ 1,754,307	$ 2,029	$ 2,315,399	$ (525,158)	$ (21,625)	$ (16,338)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	38,173			36,702		1,471
Other comprehensive (loss) income	(2,795)				(2,795)
Stock-based compensation (in shares)		290,000
Stock-based compensation	4,728	$ 3	4,725
Stock options exercised (in shares)		189,000
Stock options exercised	1,055	$ 1	1,054
Taxes withheld on issuance of stock-based awards	(2,639)		(2,639)
Dividends declared to common stockholders	(15,465)			(15,465)
Cumulative translation adjustments	208					208
Ending balance (in shares) at Mar. 31, 2022		203,345,000
Ending balance at Mar. 31, 2022	1,777,572	$ 2,033	2,318,539	(503,921)	(24,420)	(14,659)
Beginning balance (in shares) at Dec. 31, 2021		202,866,000
Beginning balance at Dec. 31, 2021	1,754,307	$ 2,029	2,315,399	(525,158)	(21,625)	(16,338)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	90,294
Other comprehensive (loss) income	(15,648)
Ending balance (in shares) at Sep. 30, 2022		199,340,000
Ending balance at Sep. 30, 2022	1,694,720	$ 1,993	2,276,094	(530,128)	(37,273)	(15,966)
Beginning balance (in shares) at Mar. 31, 2022		203,345,000
Beginning balance at Mar. 31, 2022	1,777,572	$ 2,033	2,318,539	(503,921)	(24,420)	(14,659)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	28,896			27,342		1,554
Other comprehensive (loss) income	17,836				17,836
Stock-based compensation (in shares)		64,000
Stock-based compensation	5,071	$ 1	5,070
Stock options exercised (in shares)		312,000
Stock options exercised	2,090	$ 3	2,087
Taxes withheld on issuance of stock-based awards	(739)		(739)
Dividends declared to common stockholders	(15,494)			(15,494)
Repurchase and cancellation of common stock (in shares)		(790,000)
Repurchase and cancellation of common stock	(20,016)	$ (8)	(8,992)	(11,016)
Distributions to noncontrolling interest	(2,369)					(2,369)
Cumulative translation adjustments	8					8
Ending balance (in shares) at Jun. 30, 2022		202,931,000
Ending balance at Jun. 30, 2022	1,792,855	$ 2,029	2,315,965	(503,089)	(6,584)	(15,466)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	23,225			23,068		157
Other comprehensive (loss) income	(30,689)				(30,689)
Stock-based compensation (in shares)		20,000
Stock-based compensation	5,009		5,009
Stock options exercised (in shares)		87,000
Stock options exercised	564	$ 1	563
Taxes withheld on issuance of stock-based awards	(198)		(198)
Dividends declared to common stockholders	(15,315)			(15,315)
Repurchase and cancellation of common stock (in shares)		(3,698,000)
Repurchase and cancellation of common stock	(80,074)	$ (37)	(45,245)	(34,792)
Distributions to noncontrolling interest	(647)					(647)
Cumulative translation adjustments	(10)					(10)
Ending balance (in shares) at Sep. 30, 2022		199,340,000
Ending balance at Sep. 30, 2022	$ 1,694,720	$ 1,993	2,276,094	(530,128)	(37,273)	(15,966)
Beginning balance (in shares) at Dec. 31, 2022	198,500,000	198,466,000
Beginning balance at Dec. 31, 2022	$ 1,677,215	$ 1,985	2,249,698	(527,603)	(29,530)	(17,335)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	63,144			63,532		(388)
Other comprehensive (loss) income	(15,312)				(15,312)
Stock-based compensation (in shares)		327,000
Stock-based compensation	5,234	$ 3	5,231
Stock options exercised (in shares)		481,000
Stock options exercised	3,014	$ 5	3,009
Taxes withheld on issuance of stock-based awards	(5,100)		(5,100)
Dividends declared to common stockholders	(16,784)			(16,784)
Repurchase and cancellation of common stock (in shares)		(1,302,000)
Repurchase and cancellation of common stock	(40,427)	$ (13)	(14,811)	(25,603)
Distributions to noncontrolling interest	(823)					(823)
Cumulative translation adjustments	8					8
Ending balance (in shares) at Mar. 31, 2023		197,972,000
Ending balance at Mar. 31, 2023	$ 1,670,169	$ 1,980	2,238,027	(506,458)	(44,842)	(18,538)
Beginning balance (in shares) at Dec. 31, 2022	198,500,000	198,466,000
Beginning balance at Dec. 31, 2022	$ 1,677,215	$ 1,985	2,249,698	(527,603)	(29,530)	(17,335)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	240,562
Other comprehensive (loss) income	$ (13,084)
Repurchase and cancellation of common stock (in shares)	(5,069,102)
Repurchase and cancellation of common stock	$ (159,700)
Ending balance (in shares) at Sep. 30, 2023	195,000,000.0	194,986,000
Ending balance at Sep. 30, 2023	$ 1,706,128	$ 1,950	2,204,974	(442,831)	(42,614)	(15,351)
Beginning balance (in shares) at Mar. 31, 2023		197,972,000
Beginning balance at Mar. 31, 2023	1,670,169	$ 1,980	2,238,027	(506,458)	(44,842)	(18,538)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	96,626			95,797		829
Other comprehensive (loss) income	9,149				9,149
Stock-based compensation (in shares)		180,000
Stock-based compensation	6,341	$ 2	6,339
Stock options exercised (in shares)		27,000
Stock options exercised	24		24
Taxes withheld on issuance of stock-based awards	(2,039)		(2,039)
Dividends declared to common stockholders	(16,758)			(16,758)
Repurchase and cancellation of common stock (in shares)		(1,883,000)
Repurchase and cancellation of common stock	(51,190)	$ (19)	(21,442)	(29,729)
Ending balance (in shares) at Jun. 30, 2023		196,296,000
Ending balance at Jun. 30, 2023	1,712,322	$ 1,963	2,220,909	(457,148)	(35,693)	(17,709)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	80,792			77,711		3,081
Other comprehensive (loss) income	(6,921)				(6,921)
Stock-based compensation (in shares)		129,000
Stock-based compensation	6,089	$ 1	6,088
Stock options exercised (in shares)		444,000
Stock options exercised	2,759	$ 5	2,754
Taxes withheld on issuance of stock-based awards	(2,593)		(2,593)
Dividends declared to common stockholders	$ (16,718)			(16,718)
Repurchase and cancellation of common stock (in shares)	(1,883,123)	(1,883,000)
Repurchase and cancellation of common stock	$ (68,113)	$ (19)	(21,418)	(46,676)
Distributions to noncontrolling interest	(1,482)		(766)			(716)
Cumulative translation adjustments	$ (7)					(7)
Ending balance (in shares) at Sep. 30, 2023	195,000,000.0	194,986,000
Ending balance at Sep. 30, 2023	$ 1,706,128	$ 1,950	$ 2,204,974	$ (442,831)	$ (42,614)	$ (15,351)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) (Parenthetical) - $ / shares		3 Months Ended
	Aug. 10, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022
Statement of Stockholders' Equity [Abstract]
Dividends declared to common shareholders (in dollars per share)	$ 0.085	$ 0.085	$ 0.085	$ 0.085	$ 0.075	$ 0.075	$ 0.075

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net income	$ 240,562	$ 90,294
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization	177,226	177,761
Loss on disposal group	12,965	16,515
Stock-based compensation	17,664	14,808
Provision for inventory obsolescence and write-downs	16,354	21,214
Loss on debt extinguishment	0	4,043
Deferred income taxes	(15,380)	(37,505)
Gain on disposal of fixed assets	(1,480)	(4,428)
Amortization of deferred loan costs and accretion of discount	3,044	2,736
Other	4,791	1,261
Changes in operating assets and liabilities (net of effects of foreign exchange):
Receivables	85,181	(50,075)
Inventories	(50,011)	(72,298)
Leased assets	(38,597)	(20,947)
Other assets	17,470	24,022
Accounts payable	(7,018)	38,600
Other liabilities	(91,453)	12,266
Net cash flows provided by operating activities	371,318	218,267
Cash flows from investing activities:
Capital expenditures	(110,965)	(74,752)
Proceeds from sale of fixed assets	12,328	16,424
Acquisitions, net of cash acquired	0	(3,198)
Net cash used for investing activities	(98,637)	(61,526)
Cash flows from financing activities:
Proceeds from long-term debt	15,500	995,038
Repayment of long-term debt	(43,625)	(1,071,386)
Payment of debt issue costs	(1,028)	(8,008)
Repurchases of common stock	(159,730)	(100,090)
Dividends paid	(48,309)	(30,480)
Payments related to taxes withheld on stock-based compensation	(9,732)	(3,576)
Proceeds from exercise of stock options	5,797	3,709
Payment of finance lease obligations	(7,148)	(4,503)
Distributions to noncontrolling interest	(2,305)	(3,016)
Proceeds expected to be remitted under the Accounts Receivable Facility	14,032	7,111
Net cash used for financing activities	(236,548)	(215,201)
Effect of exchange rate changes on cash and cash equivalents	(1,314)	(5,746)
Net increase (decrease) in cash and cash equivalents	34,819	(64,206)
Cash and cash equivalents at beginning of period	250,187	255,178
Cash and cash equivalents at end of period	$ 285,006	$ 190,972

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Description of the Business ChampionX Corporation is a global leader in chemistry solutions, artificial lift systems, and highly engineered equipment and technologies that help companies drill for and produce oil and gas safely, efficiently, and sustainably around the world. Our expertise, innovative products, and digital technologies provide enhanced oil and gas production, transportation, and real-time emissions monitoring throughout the lifecycle of a well. Unless the context requires otherwise, references in this report to “we,” “us,” “our,” “the Company,” or “ChampionX” mean ChampionX Corporation, together with its subsidiaries where the context requires. Basis of Presentation The accompanying unaudited condensed consolidated financial statements of ChampionX have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission pertaining to interim financial information. As permitted under those rules, certain footnotes or other financial information that are normally required by GAAP have been condensed or omitted. Therefore, these financial statements should be read in conjunction with the audited consolidated financial statements, and notes thereto, which are included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Although these estimates are based on management’s best knowledge of current events and actions that we may undertake in the future, actual results may differ from our estimates. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments unless otherwise specified) necessary for a fair statement of our financial condition and results of operations as of and for the periods presented. Revenue, expenses, assets and liabilities can vary during each quarter of the year. Therefore, the results and trends in these financial statements may not be representative of the results that may be expected for the year ending December 31, 2023. Significant Accounting Policies Please refer to “Note 1–Basis of Presentation and Summary of Significant Accounting Policies” to our consolidated financial statements in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 for the discussion of our significant accounting policies. New Accounting Standards Issued In September 2022, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2022-04, “Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations,” which requires that a buyer in a supplier finance program disclose information about the key terms of the program, outstanding confirmed amounts as of the end of the period, a rollforward of such amounts during each annual period, and a description of where in the financial statements outstanding amounts are presented. The ASU does not affect the recognition, measurement or financial statement presentation of obligations covered by supplier finance programs. The guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023, with early adoption permitted. The adoption of this ASU did not have a material effect on our consolidated financial statements, other than the newly required disclosures. See Note 15—Supply Chain Finance for information on our supplier finance program.

SEGMENT INFORMATION

9 Months Ended

Sep. 30, 2023

Segment Reporting [Abstract]

SEGMENT INFORMATION

Our reporting segments are:

•Drilling Technologies—designs, manufactures and markets polycrystalline diamond cutters and bearings for use in oil and gas drill bits under the US Synthetic brand.

Segment revenue and segment operating profit


	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Segment revenue:
Production Chemical Technologies	$	604,254	$	643,604	$	1,770,240	$	1,710,987
Production & Automation Technologies	256,148		247,717		761,852		710,465
Drilling Technologies	54,869		60,965		168,900		175,682
Reservoir Chemical Technologies	25,093		35,485		74,752		119,499
Corporate and other (1)	(581)		33,790		38,986		103,460
Total revenue	$	939,783	$	1,021,561	$	2,814,730	$	2,820,093

Segment operating profit (loss):
Production Chemical Technologies	$	94,560	$	86,649	$	248,037	$	143,518
Production & Automation Technologies	28,299		22,485		96,299		70,845
Drilling Technologies	12,255		14,856		36,802		45,119
Reservoir Chemical Technologies	2,461		(61,711)		6,634		(73,327)
Total segment operating profit	137,575		62,279		387,772		186,155
Corporate and other (1)	14,030		13,354		37,122		43,044
Interest expense, net	13,744		11,454		40,754		33,582
Income before income taxes	$	109,801	$	37,471	$	309,896	$	109,529

_______________________

REVENUE

9 Months Ended

Sep. 30, 2023

Revenue from Contract with Customer [Abstract]

REVENUE

Revenue disaggregated by geography was as follows:


	Three Months Ended September 30, 2023
(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Corporate and other (1)		Total
United States	$	250,980	$	191,139	$	41,314	$	14,131	$	(30)	$	497,534
Latin America	136,714		5,400		—		2,821		—		144,935
Middle East & Africa	75,086		17,889		2,218		6,959		(547)		101,605
Canada	73,107		20,362		3,661		257		—		97,387
Europe	47,791		4,680		6,289		714		(4)		59,470
Asia-Pacific	15,075		3,846		1,387		199		—		20,507
Australia	5,501		12,832		—		12		—		18,345
Other	—		—		—		—		—		—
Total revenue	$	604,254	$	256,148	$	54,869	$	25,093	$	(581)	$	939,783

	Three Months Ended September 30, 2022
(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Corporate and other (1)		Total
United States	$	228,007	$	192,914	$	47,645	$	19,756	$	19,651	$	507,973
Latin America	184,964		4,963		7		3,283		758		193,975
Middle East & Africa	77,162		15,567		1,562		8,314		1,358		103,963
Canada	75,334		18,922		4,614		334		49		99,253
Europe	50,206		2,776		5,774		1,102		3,584		63,442
Asia-Pacific	8,851		1,528		1,363		767		8,390		20,899
Australia	5,518		10,803		—		30		—		16,351
Other	13,562		244		—		1,899		—		15,705
Total revenue	$	643,604	$	247,717	$	60,965	$	35,485	$	33,790	$	1,021,561


	Nine Months Ended September 30, 2023
(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Corporate and other (1)		Total
United States	$	729,658	$	581,335	$	128,507	$	38,381	$	20,574	$	1,498,455
Latin America	377,268		15,545		—		9,833		1,719		404,365
Middle East & Africa	233,849		48,066		7,666		20,819		(985)		309,415
Canada	219,674		56,547		10,350		1,215		18		287,804
Europe	151,009		14,619		18,993		1,857		5,121		191,599
Asia-Pacific	32,866		9,451		3,382		2,070		12,539		60,308
Australia	16,586		36,289		—		14		—		52,889
Other	9,330		—		2		563		—		9,895
Total revenue	$	1,770,240	$	761,852	$	168,900	$	74,752	$	38,986	$	2,814,730

	Nine Months Ended September 30, 2022
(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Corporate and other (1)		Total
United States	$	624,370	$	548,698	$	140,312	$	76,015	$	61,544	$	1,450,939
Latin America	409,109		16,324		7		10,094		2,388		437,922
Middle East & Africa	227,234		51,340		4,471		21,596		1,959		306,600
Canada	223,714		55,858		11,032		1,445		112		292,161
Europe	145,116		8,505		14,640		2,973		10,352		181,586
Asia-Pacific	26,852		3,983		5,180		2,721		27,105		65,841
Australia	16,321		25,386		15		229		—		41,951
Other	38,271		371		25		4,426		—		43,093
Total revenue	$	1,710,987	$	710,465	$	175,682	$	119,499	$	103,460	$	2,820,093

______________________

Revenue is attributed to regions based on the location of our direct customer, which in some instances is an intermediary and not necessarily the end user.

Contract Balances

The beginning and ending contract asset and contract liability balances from contracts with customers were as follows:


(in thousands)	September 30, 2023		December 31, 2022
Contract assets	$	—	$	—
Contract liabilities - current	$	25,875	$	14,113

INTANGIBLE ASSETS AND GOODWILL

9 Months Ended

Sep. 30, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

INTANGIBLE ASSETS AND GOODWILL

Intangible Assets

The components of our definite- and indefinite-lived intangible assets were as follows:


	September 30, 2023						December 31, 2022
(in thousands)	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Definite-lived intangible assets:
Customer relationships	$	582,095	$	429,885	$	152,210	$	582,466	$	407,212	$	175,254
Unpatented technologies	142,760		70,504		72,256		142,760		56,264		86,496
Favorable supply agreements	57,000		57,000		—		57,000		49,056		7,944
Trademarks	59,856		38,750		21,106		59,856		36,048		23,808
Patents	36,244		30,240		6,004		38,175		31,481		6,694
Other	525		525		—		1,892		1,878		14
	878,480		626,904		251,576		882,149		581,939		300,210
Indefinite-lived intangible assets:
Trademarks	3,600		—		3,600		3,600		—		3,600
In-process research and development	1,200		—		1,200		1,200		—		1,200
	4,800		—		4,800		4,800		—		4,800
Total	$	883,280	$	626,904	$	256,376	$	886,949	$	581,939	$	305,010

Goodwill

The carrying amount of goodwill, including changes therein, by reportable segment is below:


(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Total
December 31, 2022	$	367,084	$	211,268	$	101,136	$	—	$	679,488



Foreign currency translation	(13,328)		(52)		—		—		(13,380)
September 30, 2023	$	353,756	$	211,216	$	101,136	$	—	$	666,108

Goodwill is not subject to amortization but is tested for impairment on an annual basis or more frequently if impairment indicators arise.

DEBT

9 Months Ended

Sep. 30, 2023

Debt Disclosure [Abstract]

DEBT

Long-term debt consisted of the following:


(in thousands)	September 30, 2023		December 31, 2022
2022 Revolving Credit Facility	$	—	$	25,000
2022 Term Loan Facility	620,312		623,438
Total	620,312		648,438
Net unamortized discounts and issuance costs	(19,119)		(20,486)
Total long-term debt	601,193		627,952
Current portion of long-term debt (1)	(6,250)		(6,250)
Long-term debt, less current portion	$	594,943	$	621,702

_______________________

(1) Includes the mandatory amortization payments due within twelve months related to the 2022 Term Loan Facility as of September 30, 2023.

COMMITMENTS AND CONTINGENCIES	9 Months Ended
COMMITMENTS AND CONTINGENCIES	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES The Company is subject to various claims and contingencies related to, among other things, workers’ compensation, general liability (including product liability), automobile claims, health care claims, environmental matters, and lawsuits. We record liabilities where a contingent loss is probable and can be reasonably estimated. If the reasonable estimate of a probable loss is a range, the Company records the most probable estimate of the loss or the minimum amount when no amount within the range is a better estimate than any other amount. In accordance with applicable GAAP, the Company discloses a contingent liability even if the liability is not probable or the amount is not estimable, or both, if there is a reasonable possibility that a material loss may have been incurred. Guarantees and Indemnifications We have provided indemnities in connection with sales of certain businesses and assets, including indemnities for environmental health and safety, tax, and employment matters. We do not have any material liabilities recorded for these indemnifications and are not aware of any claims or other information that would give rise to material payments under such indemnities. As of September 30, 2023 and December 31, 2022, we had $78.3 million and $82.4 million, respectively, of outstanding letters of credit, surety bonds and guarantees, which expire at various dates through 2039. These financial instruments are primarily maintained as security for insurance, warranty, and other performance obligations. Generally, we would only be liable for the amount of these letters of credit, surety bonds, and guarantees in the event of default in the performance of our obligations, the probability of which we believe is remote. Litigation and Environmental Matters The Company is party to various proceedings and claims incidental to its business, including matters arising under provisions relating to the protection of the environment. We review the probable outcome of such proceedings, the costs and expenses reasonably expected to be incurred and accrued to date, and the availability and extent of insurance coverage. We accrue a liability for legal matters that are probable and can be reasonably estimated. If the reasonable estimate of a probable loss is a range, the Company records the most probable estimate of the loss or the minimum amount when no amount within the range is a better estimate than any other amount. While many of these matters involve inherent uncertainty, we believe that the amount of the liability, if any, ultimately incurred with respect to these proceedings and claims will not have a material adverse effect on our consolidated financial position, results of operations or cash flows. Environmental Matters The Company is currently participating in environmental assessments and remediation at approximately 8 locations, the majority of which are in the United States (“U.S.”). Environmental liabilities have been accrued to reflect our best estimate of future costs. Potential insurance reimbursements are not anticipated in the Company’s accruals for environmental liabilities. As of September 30, 2023 and December 31, 2022, environmental liability accruals related to these locations were $5.9 million and $5.9 million, respectively. Prior to the commencement of our operations as an independent publicly traded company in 2018, groundwater contamination was discovered at the Norris Sucker Rods plant site located in Tulsa, Oklahoma. Initial remedial efforts were undertaken at the time of discovery of the contamination and we have since coordinated monitoring and remediation with the Oklahoma Department of Environmental Quality (“ODEQ”). As part of the ongoing long-term remediation process, we contracted an engineering and consulting firm to develop a range of possible additional remedial alternatives in order to accelerate the remediation process and associated cost estimates for the work. In October 2019, we received the firm’s preliminary remedial alternatives for consideration. We have submitted our long-term remediation plan and it was approved by ODEQ. We are now in discussion with ODEQ to finalize a consent order. Because we have not yet finalized the consent order for further remediation at the site and discussions with ODEQ remain ongoing, we cannot fully anticipate the timing, outcome or possible impact of such further remedial activities, financial or otherwise. As a result of the recommendations in the report, we accrued liabilities for these remediation efforts of approximately $2.0 million as of December 31, 2019. Liabilities could increase in the future at such time as we ultimately reach agreement with ODEQ on our remediation plan and such liabilities become probable and can be reasonably estimated; however, there have been no changes to our estimated liability as of September 30, 2023. Matters Related to Deepwater Horizon Incident Response On April 22, 2010, the deepwater drilling platform, the Deepwater Horizon, operated by a subsidiary of BP plc, sank in the Gulf of Mexico after an explosion and fire, resulting in a massive oil spill. Certain entities that are now subsidiaries of ChampionX as a result of the acquisition of the Chemical Technologies business in 2020 (collectively the “COREXIT Defendants”) supplied COREXIT™ 9500, an oil dispersant product listed on the U.S. EPA National Contingency Plan Product Schedule, which was used in the response to the spill. In connection with the provision of COREXIT™ 9500, the COREXIT Defendants were named in several lawsuits. Cases arising out of the Deepwater Horizon accident were administratively transferred and consolidated for pre-trial purposes under In Re: Oil Spill by the Oil Rig “Deepwater Horizon” in the Gulf of Mexico, on April 20, 2010, Case No. 10-md-02179 in the United States District Court in the Eastern District of Louisiana (E.D. La.) (“MDL 2179”). Claims related to the response to the oil spill were consolidated in a master complaint captioned the “B3 Master Complaint.” In 2011, Transocean Deepwater Drilling, Inc. and its affiliates (the “Transocean Entities”) named the COREXIT Defendants and other unaffiliated companies as first party defendants (In re the Complaint and Petition of Triton Asset Leasing GmbH, et al, MDL No. 2179, Civil Action 10-2771). In April and May 2011, the Transocean Entities, Cameron International Corporation, Halliburton Energy Services, Inc., M-I L.L.C., Weatherford U.S., L.P. and Weatherford International, Inc. (collectively, the “Cross Claimants”) filed cross claims in MDL 2179 against the COREXIT Defendants and other unaffiliated cross defendants. In April and June 2011, in support of its defense of the claims against it, the COREXIT Defendants filed counterclaims against the Cross Claimants. On May 18, 2012, the COREXIT Defendants filed a motion for summary judgment as to the claims in the B3 Master Complaint. On November 28, 2012, the Court granted the COREXIT Defendants’ motion and dismissed with prejudice the claims in the B3 Master Complaint asserted against the COREXIT Defendants. There currently remains one “B3” case that asserted claims against the COREXIT Defendants and that remains pending against other defendants. Because the Court’s decision was not a “final judgment” for purposes of appeal with respect to those claims, under Federal Rule of Appellate Procedure 4(a), the plaintiff will have 30 days after entry of final judgment in the case to appeal the Court’s summary judgment decision. The Company intends to vigorously defend these lawsuits and also believes that it has rights to contribution and/or indemnification (including legal expenses) from third parties. However, we cannot predict the outcome of these lawsuits, the involvement it might have in these matters in the future, or the potential for future litigation.

RESTRUCTURING EXPENSE

9 Months Ended

Sep. 30, 2023

Restructuring and Related Activities [Abstract]

RESTRUCTURING EXPENSE

RESTRUCTURING EXPENSEWe approved various restructuring plans related to the consolidation of product lines and associated facility closures and workforce reductions during prior periods, which we expect to be completed during 2023. We recognized charges of $0.1 million and $6.3 million during the three and nine months ended September 30, 2023, respectively, consisting primarily of contract termination costs, inventory obsolescence, and employee severance and related benefits. During the three and nine months ended September 30, 2022, we recorded restructuring expense of $69.8 million and $84.9 million, respectively.

The following table presents the restructuring expense by segment as classified in our condensed consolidated statements of income.


	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Segment restructuring expense (income):
Production Chemical Technologies	$	58	$	(335)	$	4,636	$	11,637
Production & Automation Technologies	—		4,282		785		260
Drilling Technologies	—		—		—		—
Reservoir Chemical Technologies	32		63,458		855		69,559
Corporate and other	—		2,350		4		3,403
Total	$	90	$	69,755	$	6,280	$	84,859

Statements of Income classification:
Cost of goods and services	$	29	$	66,488	$	2,573	$	67,496
Selling, general and administrative expense	61		3,267		3,707		17,363
Total	$	90	$	69,755	$	6,280	$	84,859

The following table details our restructuring accrual activities during the nine months ended September 30, 2023:


(in thousands)	Restructuring Accrual Balance
December 31, 2022	$	28,518
Restructuring charges	6,280
Asset sales and write-offs	(705)
Payments	(17,432)
Other, including foreign currency translation	(3)
September 30, 2023	$	16,658

STOCKHOLDERS' EQUITY	9 Months Ended
STOCKHOLDERS' EQUITY	Sep. 30, 2023
Stockholders' Equity Note [Abstract]
STOCKHOLDERS' EQUITY	STOCKHOLDERS' EQUITY Dividends On February 16, 2023, the Company announced that our Board of Directors (“Board”) approved an increase of our regular quarterly cash dividend to $0.085 per share of the Company’s common stock. Our third quarter cash dividend of $0.085 per share was declared on August 10, 2023 and is payable on October 27, 2023 to shareholders of record on October 6, 2023. As a result, we recorded a dividend payable of $17.3 million on our condensed consolidated balance sheet as of September 30, 2023. Subsequent dividend declarations, if any, including the amounts and timing of future dividends, are subject to approval by the Board and will depend on future business conditions, financial conditions, results of operations and other factors. Repurchases On March 7, 2022, the Company announced that our Board authorized the Company to repurchase up to $250 million of its common stock. On October 24, 2022, our Board increased the authorization under this program to $750 million. This program has no time limit and does not obligate the Company to acquire any particular amount of shares of its common stock. During the three months ended September 30, 2023, we repurchased and cancelled 1,883,123 shares of common stock for a total of $68.1 million, including commissions and excise tax. During the nine months ended September 30, 2023, we repurchased and cancelled 5,069,102 shares of common stock for a total of $159.7 million, including commissions and excise tax.

EARNINGS PER SHARE

9 Months Ended

Sep. 30, 2023

Earnings Per Share [Abstract]

EARNINGS PER SHARE

A reconciliation of the number of shares used for the basic and diluted earnings per share calculation was as follows:


	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands, except per share data)	2023		2022		2023		2022
Net income attributable to ChampionX	$	77,711	$	23,068	$	237,040	$	87,112

Weighted-average number of shares outstanding	195,881		201,421		197,058		202,600
Dilutive effect of stock-based compensation	3,711		5,101		3,967		5,555
Total shares and dilutive securities	199,592		206,522		201,025		208,155

Earnings per share attributable to ChampionX:
Basic	$	0.40	$	0.11	$	1.20	$	0.43
Diluted	$	0.39	$	0.11	$	1.18	$	0.42

ACQUISITIONS AND DIVESTITURES	9 Months Ended
ACQUISITIONS AND DIVESTITURES	Sep. 30, 2023
Business Combination and Asset Acquisition [Abstract]
ACQUISITIONS AND DIVESTITURES	ACQUISITIONS AND DIVESTITURES Acquisitions Leak Surveys, Inc. On February 23, 2022, we acquired the assets of Leak Surveys, Inc., a leader in optical gas imaging technology that provides aerial and ground-based emissions leak detection to the oil and gas industry. These assets have been included in our Production & Automation Technologies segment. Under the terms of the agreement, we paid an initial amount of $3.2 million, net of cash acquired, with an additional $0.5 million which was paid on the first anniversary of the closing date. We may also be required to make future payments of up to an additional $2.5 million, contingent on the future performance of the business. As part of our purchase price allocation, we recorded goodwill of $6.3 million in the first quarter of 2022. The pro forma effect of this acquisition on revenue and net income has been determined to be immaterial to our financial statements. Divestitures Due to the deteriorating business conditions in Russia following the Ukraine invasion and the resultant sanctions imposed by the United States, European Union, and United Kingdom, we initiated a plan to dispose of our operations in Russia (the “CT Russia Business”), which is included in our Production Chemical Technologies segment. As a result, the CT Russia Business met the criteria to be classified as held for sale during the second quarter of 2022 and we measured the carrying value of the disposal group to the lower of its carrying value or fair value less costs to sell. We assess the fair value of the CT Russia Business (less any costs to sell) each reporting period that it remains classified as held for sale and report any subsequent changes as an adjustment to the carrying value of the asset or disposal group, as long as the new carrying value does not exceed the carrying value of the asset at the time it was initially classified as held for sale. Due to the continued deterioration of the business environment, increasing trade regulations and sanctions and Russia’s imposition of an exit tax on divestments to facilitate exit from in-country operations, we assessed the fair value less cost to sell the business as of March 31, 2023 to be zero, resulting in a $13.0 million pre-tax impairment expense recorded during the three months ended March 31, 2023. There were no other changes in the nine month period ended September 30, 2023.

FAIR VALUE MEASUREMENTS

9 Months Ended

Sep. 30, 2023

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENTS

Level 1- Inputs are quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities.

Level 2- Inputs include observable inputs other than quoted prices in active markets.

Level 3- Inputs are unobservable inputs for which there is little or no market data available.

The carrying amount and the estimated fair value for assets and liabilities measured on a recurring basis are as follows:


		Carrying Amount
(in thousands)	Measurement Level	September 30, 2023		December 31, 2022
Assets
Foreign currency forward contracts	Level 2	$	3,987	$	7,066
Interest rate swaps	Level 2	12,007		8,476
Total		$	15,994	$	15,542

Liabilities
Foreign currency forward contracts	Level 2	$	2,939	$	4,209
Interest rate swaps	Level 2	—		—
Total		$	2,939	$	4,209

The carrying amounts of cash and cash equivalents, trade receivables, and accounts payable approximate their fair value due to their short-term nature.


	September 30, 2023				December 31, 2022
(in thousands)	Carrying Amount		Fair Value		Carrying Amount		Fair Value
2022 Revolving Credit Facility	$	—	$	—	$	25,000	$	25,000
2022 Term Loan Facility	$	620,312	$	627,291	$	623,438	$	610,969

DERIVATIVES AND HEDGING TRANSACTIONS

9 Months Ended

Sep. 30, 2023

Derivative Instruments and Hedging Activities Disclosure [Abstract]

DERIVATIVES AND HEDGING TRANSACTIONS

Derivative Positions Summary

The following table summarizes the gross fair value of the Company’s outstanding derivatives and the lines in which they are presented on the condensed consolidated balance sheet.


	Derivative Assets				Derivative Liabilities
(in thousands)	September 30, 2023		December 31, 2022		September 30, 2023		December 31, 2022
Prepaid expenses and other current assets	$	10,603	$	11,911	$	—	$	—
Other non-current assets	5,391		3,631		—		—
Accrued expenses and other current liabilities	—		—		2,939		4,209

	$	15,994	$	15,542	$	2,939	$	4,209

The following table summarizes the notional values of the Company’s outstanding derivatives:


(in thousands)	September 30, 2023		December 31, 2022
Notional value of foreign currency forward contracts and interest rate swaps	$	813,995	$	965,973

Cash Flow Hedges

Derivatives Not Designated as Hedging Instruments

Effect of Derivative Instruments on Income

The loss of all derivative instruments recognized is summarized below:


	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Loss (gain) reclassified from AOCI to income on cash flow hedges:
Cost of goods and services	$	(190)	$	(837)	$	(2,113)	$	(884)
Interest expense	(1,645)		585		(3,904)		585
Loss on derivatives not designated as hedging instruments:
Other (income) expense, net	778		1,167		3,125		6,578
Total loss of derivative instruments	$	(1,057)	$	915	$	(2,892)	$	6,279

INVENTORIES

9 Months Ended

Sep. 30, 2023

Inventory, Net [Abstract]

INVENTORIES

Inventories consisted of the following:


(in thousands)	September 30, 2023		December 31, 2022
Raw materials	$	149,876	$	142,571
Work in progress	18,092		19,582
Finished goods	505,053		467,628
	673,021		629,781
Inventory reserve	(30,243)		(24,702)
LIFO adjustments (1)	(53,978)		(62,536)
Inventories, net	$	588,800	$	542,543

_______________________

(1) Represents the amount by which the current cost of LIFO inventories exceeded their carrying value.

ACCOUNTS RECEIVABLE FACILITY	9 Months Ended
ACCOUNTS RECEIVABLE FACILITY	Sep. 30, 2023
Receivables [Abstract]
ACCOUNTS RECEIVABLE FACILITY	ACCOUNTS RECEIVABLE FACILITYOn June 28, 2022, we entered into an uncommitted accounts receivable purchase agreement (the “Accounts Receivable Facility”) with JPMorgan Chase Bank, N.A. as the purchaser. Transfers under the Accounts Receivable Facility are accounted for as sales of receivables, resulting in the receivables being derecognized from our condensed consolidated balance sheet. The purchaser assumes the credit risk at the time of sale and has the right at any time to assign or transfer (including as a participation interest) any of its rights under the purchased receivables to another bank or financial institution. The amount available for sale under the Accounts Receivable Facility fluctuates over time based on the total amount of eligible receivables generated during the normal course of business. A maximum of $160.0 million in receivables may be sold and remain unpaid under the Accounts Receivable Facility at any time. Accounts receivable sold were $543.4 million for the nine months ended September 30, 2023. The accounts receivable sold that remained outstanding as of September 30, 2023 was $112.9 million. During this period, cash receipts from the purchaser at the time of the sale were classified as operating activities in our condensed consolidated statement of cash flows. The difference between the carrying amount of the accounts receivable sold and the sum of the cash received is recorded as a loss on sale of receivables in other income (expense), net in our condensed consolidated statements of income. The loss on sale of accounts receivable was $1.9 million and $5.3 million for the three and nine months ended September 30, 2023, respectively.

SUPPLY CHAIN FINANCE	9 Months Ended
SUPPLY CHAIN FINANCE	Sep. 30, 2023
Investments, Debt and Equity Securities [Abstract]
SUPPLY CHAIN FINANCE	SUPPLY CHAIN FINANCEWe use a supply chain finance program in connection with the purchase of goods, which allows our suppliers to work directly with a third party to provide financing by purchasing their receivables earlier in the payment cycle. We maintain the same contractually agreed upon invoice terms prior to each supplier entering into the program. As of September 30, 2023, we had approximately $45.4 million outstanding under the program, which is included in accounts payable on our condensed consolidated balance sheet.

CASH FLOW INFORMATION	9 Months Ended
CASH FLOW INFORMATION	Sep. 30, 2023
Supplemental Cash Flow Elements [Abstract]
CASH FLOW INFORMATION	CASH FLOW INFORMATION Leased Asset Program Our electrical submersible pumping leased asset program is reported in our Production & Automation Technologies segment. At the time of purchase, assets are recorded to inventory and are transferred to property, plant, and equipment when a customer contracts for an asset under our leased asset program. During the nine months ended September 30, 2023 and 2022, we transferred $77.2 million and $32.1 million, respectively, of inventory into property, plant, and equipment as a result of assets entering our leased asset program. Expenditures for assets that are placed into our leased asset program expected to be recovered through sale are reported in leased assets in the operating section of our condensed consolidated statements of cash flows. All other capitalizable expenditures for assets that are placed into our leased asset program are classified as capital expenditures in the investing section of our condensed consolidated statements of cash flows.

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Pay vs Performance Disclosure
Net income attributable to ChampionX	$ 77,711	$ 23,068	$ 237,040	$ 87,112

Insider Trading Arrangements
shares in Thousands

3 Months Ended

9 Months Ended

Sep. 30, 2023

Trading Arrangements, by Individual

Material Terms of Trading Arrangement

Name & Title

Date Adopted

Character of Trading Arrangement

(1)

Aggregate Number of Shares of Common Stock to be Purchased or Sold Pursuant to Trading Arrangement

Duration

(2)

Other Material Terms

Date Terminated

Deric Bryant, Chief Operating Officer and President, Chemical Technologies

August 15, 2023

Rule 10b5-1 Trading Arrangement

Up to 384,596 shares to be sold

December 31, 2024

N/A

William R. O' Dell, President, Oilfield and Specialty Performance

August 10, 2023

Rule 10b5-1 Trading Arrangement

Up to 27,178 shares to be sold

August 30, 2024

N/A

_______________________

(1)Each trading arrangement marked as a “Rule 10b5-1 Trading Arrangement” is intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act, (the “Rule”).

Non-Rule 10b5-1 Arrangement Adopted

false

Rule 10b5-1 Arrangement Terminated

false

Non-Rule 10b5-1 Arrangement Terminated

false

Deric Bryant [Member]

Trading Arrangements, by Individual

Name

Deric Bryant

Title

Chief Operating Officer and President, Chemical Technologies

Rule 10b5-1 Arrangement Adopted

true

Adoption Date

August 15, 2023

Arrangement Duration

504 days

Aggregate Available

384,596

William R. O’Dell [Member]

Trading Arrangements, by Individual

Name

William R. O' Dell

Title

President, Oilfield and Specialty Performance

Rule 10b5-1 Arrangement Adopted

true

Adoption Date

August 10, 2023

Arrangement Duration

387 days

Aggregate Available

27,178

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements of ChampionX have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission pertaining to interim financial information. As permitted under those rules, certain footnotes or other financial information that are normally required by GAAP have been condensed or omitted. Therefore, these financial statements should be read in conjunction with the audited consolidated financial statements, and notes thereto, which are included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Although these estimates are based on management’s best knowledge of current events and actions that we may undertake in the future, actual results may differ from our estimates. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments unless otherwise specified) necessary for a fair statement of our financial condition and results of operations as of and for the periods presented. Revenue, expenses, assets and liabilities can vary during each quarter of the year. Therefore, the results and trends in these financial statements may not be representative of the results that may be expected for the year ending December 31, 2023.
New Accounting Standards Issued	New Accounting Standards Issued In September 2022, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2022-04, “Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations,” which requires that a buyer in a supplier finance program disclose information about the key terms of the program, outstanding confirmed amounts as of the end of the period, a rollforward of such amounts during each annual period, and a description of where in the financial statements outstanding amounts are presented. The ASU does not affect the recognition, measurement or financial statement presentation of obligations covered by supplier finance programs. The guidance is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023, with early adoption permitted. The adoption of this ASU did not have a material effect on our consolidated financial statements, other than the newly required disclosures. See Note 15—Supply Chain Finance for information on our supplier finance program.
Fair Value Measurements	Fair value is defined as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. A hierarchy has been established for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring the most observable inputs be used when available. The hierarchy is broken down into three levels: Level 1- Inputs are quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities. Level 2- Inputs include observable inputs other than quoted prices in active markets. Level 3- Inputs are unobservable inputs for which there is little or no market data available.

SEGMENT INFORMATION (Tables)

9 Months Ended

Sep. 30, 2023

Segment Reporting [Abstract]

Schedule of Segment Revenue and Operating Profit

Segment revenue and segment operating profit


	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Segment revenue:
Production Chemical Technologies	$	604,254	$	643,604	$	1,770,240	$	1,710,987
Production & Automation Technologies	256,148		247,717		761,852		710,465
Drilling Technologies	54,869		60,965		168,900		175,682
Reservoir Chemical Technologies	25,093		35,485		74,752		119,499
Corporate and other (1)	(581)		33,790		38,986		103,460
Total revenue	$	939,783	$	1,021,561	$	2,814,730	$	2,820,093

Segment operating profit (loss):
Production Chemical Technologies	$	94,560	$	86,649	$	248,037	$	143,518
Production & Automation Technologies	28,299		22,485		96,299		70,845
Drilling Technologies	12,255		14,856		36,802		45,119
Reservoir Chemical Technologies	2,461		(61,711)		6,634		(73,327)
Total segment operating profit	137,575		62,279		387,772		186,155
Corporate and other (1)	14,030		13,354		37,122		43,044
Interest expense, net	13,744		11,454		40,754		33,582
Income before income taxes	$	109,801	$	37,471	$	309,896	$	109,529

_______________________

REVENUE (Tables)

9 Months Ended

Sep. 30, 2023

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

Revenue disaggregated by geography was as follows:


	Three Months Ended September 30, 2023
(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Corporate and other (1)		Total
United States	$	250,980	$	191,139	$	41,314	$	14,131	$	(30)	$	497,534
Latin America	136,714		5,400		—		2,821		—		144,935
Middle East & Africa	75,086		17,889		2,218		6,959		(547)		101,605
Canada	73,107		20,362		3,661		257		—		97,387
Europe	47,791		4,680		6,289		714		(4)		59,470
Asia-Pacific	15,075		3,846		1,387		199		—		20,507
Australia	5,501		12,832		—		12		—		18,345
Other	—		—		—		—		—		—
Total revenue	$	604,254	$	256,148	$	54,869	$	25,093	$	(581)	$	939,783

	Three Months Ended September 30, 2022
(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Corporate and other (1)		Total
United States	$	228,007	$	192,914	$	47,645	$	19,756	$	19,651	$	507,973
Latin America	184,964		4,963		7		3,283		758		193,975
Middle East & Africa	77,162		15,567		1,562		8,314		1,358		103,963
Canada	75,334		18,922		4,614		334		49		99,253
Europe	50,206		2,776		5,774		1,102		3,584		63,442
Asia-Pacific	8,851		1,528		1,363		767		8,390		20,899
Australia	5,518		10,803		—		30		—		16,351
Other	13,562		244		—		1,899		—		15,705
Total revenue	$	643,604	$	247,717	$	60,965	$	35,485	$	33,790	$	1,021,561


	Nine Months Ended September 30, 2023
(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Corporate and other (1)		Total
United States	$	729,658	$	581,335	$	128,507	$	38,381	$	20,574	$	1,498,455
Latin America	377,268		15,545		—		9,833		1,719		404,365
Middle East & Africa	233,849		48,066		7,666		20,819		(985)		309,415
Canada	219,674		56,547		10,350		1,215		18		287,804
Europe	151,009		14,619		18,993		1,857		5,121		191,599
Asia-Pacific	32,866		9,451		3,382		2,070		12,539		60,308
Australia	16,586		36,289		—		14		—		52,889
Other	9,330		—		2		563		—		9,895
Total revenue	$	1,770,240	$	761,852	$	168,900	$	74,752	$	38,986	$	2,814,730

	Nine Months Ended September 30, 2022
(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Corporate and other (1)		Total
United States	$	624,370	$	548,698	$	140,312	$	76,015	$	61,544	$	1,450,939
Latin America	409,109		16,324		7		10,094		2,388		437,922
Middle East & Africa	227,234		51,340		4,471		21,596		1,959		306,600
Canada	223,714		55,858		11,032		1,445		112		292,161
Europe	145,116		8,505		14,640		2,973		10,352		181,586
Asia-Pacific	26,852		3,983		5,180		2,721		27,105		65,841
Australia	16,321		25,386		15		229		—		41,951
Other	38,271		371		25		4,426		—		43,093
Total revenue	$	1,710,987	$	710,465	$	175,682	$	119,499	$	103,460	$	2,820,093

______________________

Schedule of Contract Balances

The beginning and ending contract asset and contract liability balances from contracts with customers were as follows:


(in thousands)	September 30, 2023		December 31, 2022
Contract assets	$	—	$	—
Contract liabilities - current	$	25,875	$	14,113

INTANGIBLE ASSETS AND GOODWILL (Tables)

9 Months Ended

Sep. 30, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Finite-Lived Intangible Assets

The components of our definite- and indefinite-lived intangible assets were as follows:


	September 30, 2023						December 31, 2022
(in thousands)	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Definite-lived intangible assets:
Customer relationships	$	582,095	$	429,885	$	152,210	$	582,466	$	407,212	$	175,254
Unpatented technologies	142,760		70,504		72,256		142,760		56,264		86,496
Favorable supply agreements	57,000		57,000		—		57,000		49,056		7,944
Trademarks	59,856		38,750		21,106		59,856		36,048		23,808
Patents	36,244		30,240		6,004		38,175		31,481		6,694
Other	525		525		—		1,892		1,878		14
	878,480		626,904		251,576		882,149		581,939		300,210
Indefinite-lived intangible assets:
Trademarks	3,600		—		3,600		3,600		—		3,600
In-process research and development	1,200		—		1,200		1,200		—		1,200
	4,800		—		4,800		4,800		—		4,800
Total	$	883,280	$	626,904	$	256,376	$	886,949	$	581,939	$	305,010

Schedule of Indefinite-Lived Intangible Assets

The components of our definite- and indefinite-lived intangible assets were as follows:


	September 30, 2023						December 31, 2022
(in thousands)	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Definite-lived intangible assets:
Customer relationships	$	582,095	$	429,885	$	152,210	$	582,466	$	407,212	$	175,254
Unpatented technologies	142,760		70,504		72,256		142,760		56,264		86,496
Favorable supply agreements	57,000		57,000		—		57,000		49,056		7,944
Trademarks	59,856		38,750		21,106		59,856		36,048		23,808
Patents	36,244		30,240		6,004		38,175		31,481		6,694
Other	525		525		—		1,892		1,878		14
	878,480		626,904		251,576		882,149		581,939		300,210
Indefinite-lived intangible assets:
Trademarks	3,600		—		3,600		3,600		—		3,600
In-process research and development	1,200		—		1,200		1,200		—		1,200
	4,800		—		4,800		4,800		—		4,800
Total	$	883,280	$	626,904	$	256,376	$	886,949	$	581,939	$	305,010

Schedule of Goodwill

The carrying amount of goodwill, including changes therein, by reportable segment is below:


(in thousands)	Production Chemical Technologies		Production & Automation Technologies		Drilling Technologies		Reservoir Chemical Technologies		Total
December 31, 2022	$	367,084	$	211,268	$	101,136	$	—	$	679,488



Foreign currency translation	(13,328)		(52)		—		—		(13,380)
September 30, 2023	$	353,756	$	211,216	$	101,136	$	—	$	666,108

DEBT (Tables)

9 Months Ended

Sep. 30, 2023

Debt Disclosure [Abstract]

Schedule of Long-Term Debt

Long-term debt consisted of the following:


(in thousands)	September 30, 2023		December 31, 2022
2022 Revolving Credit Facility	$	—	$	25,000
2022 Term Loan Facility	620,312		623,438
Total	620,312		648,438
Net unamortized discounts and issuance costs	(19,119)		(20,486)
Total long-term debt	601,193		627,952
Current portion of long-term debt (1)	(6,250)		(6,250)
Long-term debt, less current portion	$	594,943	$	621,702

_______________________

(1) Includes the mandatory amortization payments due within twelve months related to the 2022 Term Loan Facility as of September 30, 2023.

RESTRUCTURING EXPENSE (Tables)

9 Months Ended

Sep. 30, 2023

Restructuring and Related Activities [Abstract]

Schedule of Restructuring Charges

The following table presents the restructuring expense by segment as classified in our condensed consolidated statements of income.


	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Segment restructuring expense (income):
Production Chemical Technologies	$	58	$	(335)	$	4,636	$	11,637
Production & Automation Technologies	—		4,282		785		260
Drilling Technologies	—		—		—		—
Reservoir Chemical Technologies	32		63,458		855		69,559
Corporate and other	—		2,350		4		3,403
Total	$	90	$	69,755	$	6,280	$	84,859

Statements of Income classification:
Cost of goods and services	$	29	$	66,488	$	2,573	$	67,496
Selling, general and administrative expense	61		3,267		3,707		17,363
Total	$	90	$	69,755	$	6,280	$	84,859

The following table details our restructuring accrual activities during the nine months ended September 30, 2023:


(in thousands)	Restructuring Accrual Balance
December 31, 2022	$	28,518
Restructuring charges	6,280
Asset sales and write-offs	(705)
Payments	(17,432)
Other, including foreign currency translation	(3)
September 30, 2023	$	16,658

EARNINGS PER SHARE (Tables)

9 Months Ended

Sep. 30, 2023

Earnings Per Share [Abstract]

Schedule of Earnings Per Share

A reconciliation of the number of shares used for the basic and diluted earnings per share calculation was as follows:


	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands, except per share data)	2023		2022		2023		2022
Net income attributable to ChampionX	$	77,711	$	23,068	$	237,040	$	87,112

Weighted-average number of shares outstanding	195,881		201,421		197,058		202,600
Dilutive effect of stock-based compensation	3,711		5,101		3,967		5,555
Total shares and dilutive securities	199,592		206,522		201,025		208,155

Earnings per share attributable to ChampionX:
Basic	$	0.40	$	0.11	$	1.20	$	0.43
Diluted	$	0.39	$	0.11	$	1.18	$	0.42

FAIR VALUE MEASUREMENTS (Tables)

9 Months Ended

Sep. 30, 2023

Fair Value Disclosures [Abstract]

Schedule of Assets and Liabilities Measured on Recurring Basis

The carrying amount and the estimated fair value for assets and liabilities measured on a recurring basis are as follows:


		Carrying Amount
(in thousands)	Measurement Level	September 30, 2023		December 31, 2022
Assets
Foreign currency forward contracts	Level 2	$	3,987	$	7,066
Interest rate swaps	Level 2	12,007		8,476
Total		$	15,994	$	15,542

Liabilities
Foreign currency forward contracts	Level 2	$	2,939	$	4,209
Interest rate swaps	Level 2	—		—
Total		$	2,939	$	4,209

Schedule of Fair Value of Long-Term Debt

The carrying amount and the estimated fair value of long-term debt, including current maturities, held by the Company were:


	September 30, 2023				December 31, 2022
(in thousands)	Carrying Amount		Fair Value		Carrying Amount		Fair Value
2022 Revolving Credit Facility	$	—	$	—	$	25,000	$	25,000
2022 Term Loan Facility	$	620,312	$	627,291	$	623,438	$	610,969

DERIVATIVES AND HEDGING TRANSACTIONS (Tables)

9 Months Ended

Sep. 30, 2023

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Notional Values of Outstanding Derivatives

The following table summarizes the gross fair value of the Company’s outstanding derivatives and the lines in which they are presented on the condensed consolidated balance sheet.


	Derivative Assets				Derivative Liabilities
(in thousands)	September 30, 2023		December 31, 2022		September 30, 2023		December 31, 2022
Prepaid expenses and other current assets	$	10,603	$	11,911	$	—	$	—
Other non-current assets	5,391		3,631		—		—
Accrued expenses and other current liabilities	—		—		2,939		4,209

	$	15,994	$	15,542	$	2,939	$	4,209

The following table summarizes the notional values of the Company’s outstanding derivatives:


(in thousands)	September 30, 2023		December 31, 2022
Notional value of foreign currency forward contracts and interest rate swaps	$	813,995	$	965,973

Schedule of Derivative Instruments

The loss of all derivative instruments recognized is summarized below:


	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Loss (gain) reclassified from AOCI to income on cash flow hedges:
Cost of goods and services	$	(190)	$	(837)	$	(2,113)	$	(884)
Interest expense	(1,645)		585		(3,904)		585
Loss on derivatives not designated as hedging instruments:
Other (income) expense, net	778		1,167		3,125		6,578
Total loss of derivative instruments	$	(1,057)	$	915	$	(2,892)	$	6,279

INVENTORIES (Tables)

9 Months Ended

Sep. 30, 2023

Inventory, Net [Abstract]

Components of Inventory

Inventories consisted of the following:


(in thousands)	September 30, 2023		December 31, 2022
Raw materials	$	149,876	$	142,571
Work in progress	18,092		19,582
Finished goods	505,053		467,628
	673,021		629,781
Inventory reserve	(30,243)		(24,702)
LIFO adjustments (1)	(53,978)		(62,536)
Inventories, net	$	588,800	$	542,543

_______________________

(1) Represents the amount by which the current cost of LIFO inventories exceeded their carrying value.

SEGMENT INFORMATION (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
SEGMENT INFORMATION (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Segment Reporting Information [Line Items]
Total revenue	$ 939,783	$ 1,021,561	$ 2,814,730	$ 2,820,093
Income before income taxes	109,801	37,471	309,896	109,529
Interest expense, net	13,744	11,454	40,754	33,582
Operating Segments
Segment Reporting Information [Line Items]
Income before income taxes	137,575	62,279	387,772	186,155
Operating Segments \| Production Chemical Technologies
Segment Reporting Information [Line Items]
Total revenue	604,254	643,604	1,770,240	1,710,987
Income before income taxes	94,560	86,649	248,037	143,518
Operating Segments \| Production & Automation Technologies
Segment Reporting Information [Line Items]
Total revenue	256,148	247,717	761,852	710,465
Income before income taxes	28,299	22,485	96,299	70,845
Operating Segments \| Drilling Technologies
Segment Reporting Information [Line Items]
Total revenue	54,869	60,965	168,900	175,682
Income before income taxes	12,255	14,856	36,802	45,119
Operating Segments \| Reservoir Chemical Technologies
Segment Reporting Information [Line Items]
Total revenue	25,093	35,485	74,752	119,499
Income before income taxes	2,461	(61,711)	6,634	(73,327)
Corporate and Other
Segment Reporting Information [Line Items]
Total revenue	(581)	33,790	38,986	103,460
Income before income taxes	$ 14,030	$ 13,354	$ 37,122	$ 43,044

REVENUE - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Disaggregation of Revenue [Line Items]
Total revenue	$ 939,783	$ 1,021,561	$ 2,814,730	$ 2,820,093
United States
Disaggregation of Revenue [Line Items]
Total revenue	497,534	507,973	1,498,455	1,450,939
Latin America
Disaggregation of Revenue [Line Items]
Total revenue	144,935	193,975	404,365	437,922
Middle East & Africa
Disaggregation of Revenue [Line Items]
Total revenue	101,605	103,963	309,415	306,600
Canada
Disaggregation of Revenue [Line Items]
Total revenue	97,387	99,253	287,804	292,161
Europe
Disaggregation of Revenue [Line Items]
Total revenue	59,470	63,442	191,599	181,586
Asia-Pacific
Disaggregation of Revenue [Line Items]
Total revenue	20,507	20,899	60,308	65,841
Australia
Disaggregation of Revenue [Line Items]
Total revenue	18,345	16,351	52,889	41,951
Other
Disaggregation of Revenue [Line Items]
Total revenue	0	15,705	9,895	43,093
Operating Segments \| Production Chemical Technologies
Disaggregation of Revenue [Line Items]
Total revenue	604,254	643,604	1,770,240	1,710,987
Operating Segments \| Production & Automation Technologies
Disaggregation of Revenue [Line Items]
Total revenue	256,148	247,717	761,852	710,465
Operating Segments \| Drilling Technologies
Disaggregation of Revenue [Line Items]
Total revenue	54,869	60,965	168,900	175,682
Operating Segments \| Reservoir Chemical Technologies
Disaggregation of Revenue [Line Items]
Total revenue	25,093	35,485	74,752	119,499
Operating Segments \| United States \| Production Chemical Technologies
Disaggregation of Revenue [Line Items]
Total revenue	250,980	228,007	729,658	624,370
Operating Segments \| United States \| Production & Automation Technologies
Disaggregation of Revenue [Line Items]
Total revenue	191,139	192,914	581,335	548,698
Operating Segments \| United States \| Drilling Technologies
Disaggregation of Revenue [Line Items]
Total revenue	41,314	47,645	128,507	140,312
Operating Segments \| United States \| Reservoir Chemical Technologies
Disaggregation of Revenue [Line Items]
Total revenue	14,131	19,756	38,381	76,015
Operating Segments \| Latin America \| Production Chemical Technologies
Disaggregation of Revenue [Line Items]
Total revenue	136,714	184,964	377,268	409,109
Operating Segments \| Latin America \| Production & Automation Technologies
Disaggregation of Revenue [Line Items]
Total revenue	5,400	4,963	15,545	16,324
Operating Segments \| Latin America \| Drilling Technologies
Disaggregation of Revenue [Line Items]
Total revenue	0	7	0	7
Operating Segments \| Latin America \| Reservoir Chemical Technologies
Disaggregation of Revenue [Line Items]
Total revenue	2,821	3,283	9,833	10,094
Operating Segments \| Middle East & Africa \| Production Chemical Technologies
Disaggregation of Revenue [Line Items]
Total revenue	75,086	77,162	233,849	227,234
Operating Segments \| Middle East & Africa \| Production & Automation Technologies
Disaggregation of Revenue [Line Items]
Total revenue	17,889	15,567	48,066	51,340
Operating Segments \| Middle East & Africa \| Drilling Technologies
Disaggregation of Revenue [Line Items]
Total revenue	2,218	1,562	7,666	4,471
Operating Segments \| Middle East & Africa \| Reservoir Chemical Technologies
Disaggregation of Revenue [Line Items]
Total revenue	6,959	8,314	20,819	21,596
Operating Segments \| Canada \| Production Chemical Technologies
Disaggregation of Revenue [Line Items]
Total revenue	73,107	75,334	219,674	223,714
Operating Segments \| Canada \| Production & Automation Technologies
Disaggregation of Revenue [Line Items]
Total revenue	20,362	18,922	56,547	55,858
Operating Segments \| Canada \| Drilling Technologies
Disaggregation of Revenue [Line Items]
Total revenue	3,661	4,614	10,350	11,032
Operating Segments \| Canada \| Reservoir Chemical Technologies
Disaggregation of Revenue [Line Items]
Total revenue	257	334	1,215	1,445
Operating Segments \| Europe \| Production Chemical Technologies
Disaggregation of Revenue [Line Items]
Total revenue	47,791	50,206	151,009	145,116
Operating Segments \| Europe \| Production & Automation Technologies
Disaggregation of Revenue [Line Items]
Total revenue	4,680	2,776	14,619	8,505
Operating Segments \| Europe \| Drilling Technologies
Disaggregation of Revenue [Line Items]
Total revenue	6,289	5,774	18,993	14,640
Operating Segments \| Europe \| Reservoir Chemical Technologies
Disaggregation of Revenue [Line Items]
Total revenue	714	1,102	1,857	2,973
Operating Segments \| Asia-Pacific \| Production Chemical Technologies
Disaggregation of Revenue [Line Items]
Total revenue	15,075	8,851	32,866	26,852
Operating Segments \| Asia-Pacific \| Production & Automation Technologies
Disaggregation of Revenue [Line Items]
Total revenue	3,846	1,528	9,451	3,983
Operating Segments \| Asia-Pacific \| Drilling Technologies
Disaggregation of Revenue [Line Items]
Total revenue	1,387	1,363	3,382	5,180
Operating Segments \| Asia-Pacific \| Reservoir Chemical Technologies
Disaggregation of Revenue [Line Items]
Total revenue	199	767	2,070	2,721
Operating Segments \| Australia \| Production Chemical Technologies
Disaggregation of Revenue [Line Items]
Total revenue	5,501	5,518	16,586	16,321
Operating Segments \| Australia \| Production & Automation Technologies
Disaggregation of Revenue [Line Items]
Total revenue	12,832	10,803	36,289	25,386
Operating Segments \| Australia \| Drilling Technologies
Disaggregation of Revenue [Line Items]
Total revenue	0	0	0	15
Operating Segments \| Australia \| Reservoir Chemical Technologies
Disaggregation of Revenue [Line Items]
Total revenue	12	30	14	229
Operating Segments \| Other \| Production Chemical Technologies
Disaggregation of Revenue [Line Items]
Total revenue	0	13,562	9,330	38,271
Operating Segments \| Other \| Production & Automation Technologies
Disaggregation of Revenue [Line Items]
Total revenue	0	244	0	371
Operating Segments \| Other \| Drilling Technologies
Disaggregation of Revenue [Line Items]
Total revenue	0	0	2	25
Operating Segments \| Other \| Reservoir Chemical Technologies
Disaggregation of Revenue [Line Items]
Total revenue	0	1,899	563	4,426
Corporate and other
Disaggregation of Revenue [Line Items]
Total revenue	(581)	33,790	38,986	103,460
Corporate and other \| United States
Disaggregation of Revenue [Line Items]
Total revenue	(30)	19,651	20,574	61,544
Corporate and other \| Latin America
Disaggregation of Revenue [Line Items]
Total revenue	0	758	1,719	2,388
Corporate and other \| Middle East & Africa
Disaggregation of Revenue [Line Items]
Total revenue	(547)	1,358	(985)	1,959
Corporate and other \| Canada
Disaggregation of Revenue [Line Items]
Total revenue	0	49	18	112
Corporate and other \| Europe
Disaggregation of Revenue [Line Items]
Total revenue	(4)	3,584	5,121	10,352
Corporate and other \| Asia-Pacific
Disaggregation of Revenue [Line Items]
Total revenue	0	8,390	12,539	27,105
Corporate and other \| Australia
Disaggregation of Revenue [Line Items]
Total revenue	0	0	0	0
Corporate and other \| Other
Disaggregation of Revenue [Line Items]
Total revenue	$ 0	$ 0	$ 0	$ 0

REVENUE - Contract Balances (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Contract assets	$ 0	$ 0
Contract liabilities - current	$ 25,875	$ 14,113

INTANGIBLE ASSETS AND GOODWILL - Schedule of Intangibles (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 878,480	$ 882,149
Accumulated Amortization	626,904	581,939
Net Carrying Amount	251,576	300,210
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	4,800	4,800
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Intangible assets, gross	883,280	886,949
Accumulated Amortization	626,904	581,939
Intangible assets, net	256,376	305,010
Trademarks
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	3,600	3,600
In-process research and development
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	1,200	1,200
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	582,095	582,466
Accumulated Amortization	429,885	407,212
Net Carrying Amount	152,210	175,254
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	429,885	407,212
Unpatented technologies
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	142,760	142,760
Accumulated Amortization	70,504	56,264
Net Carrying Amount	72,256	86,496
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	70,504	56,264
Favorable supply agreements
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	57,000	57,000
Accumulated Amortization	57,000	49,056
Net Carrying Amount	0	7,944
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	57,000	49,056
Trademarks
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	59,856	59,856
Accumulated Amortization	38,750	36,048
Net Carrying Amount	21,106	23,808
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	38,750	36,048
Patents
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	36,244	38,175
Accumulated Amortization	30,240	31,481
Net Carrying Amount	6,004	6,694
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	30,240	31,481
Other
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	525	1,892
Accumulated Amortization	525	1,878
Net Carrying Amount	0	14
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	$ 525	$ 1,878

INTANGIBLE ASSETS AND GOODWILL - Schedule of Goodwill (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2023 USD ($)
Goodwill [Roll Forward]
Beginning balance	$ 679,488
Foreign currency translation	(13,380)
Ending balance	666,108
Production Chemical Technologies
Goodwill [Roll Forward]
Beginning balance	367,084
Foreign currency translation	(13,328)
Ending balance	353,756
Production & Automation Technologies
Goodwill [Roll Forward]
Beginning balance	211,268
Foreign currency translation	(52)
Ending balance	211,216
Drilling Technologies
Goodwill [Roll Forward]
Beginning balance	101,136
Foreign currency translation	0
Ending balance	101,136
Reservoir Chemical Technologies
Goodwill [Roll Forward]
Beginning balance	0
Foreign currency translation	0
Ending balance	$ 0

DEBT - Long-term Debt (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Total	$ 620,312,000	$ 648,438,000
Net unamortized discounts and issuance costs	(19,119,000)	(20,486,000)
Total long-term debt	601,193,000	627,952,000
Current portion of long-term debt	(6,250,000)	(6,250,000)
Long-term debt, less current portion	594,943,000	621,702,000
2022 Term Loan Facility \| Term Loan Facility
Debt Instrument [Line Items]
Total	620,312,000	623,438,000
Revolving Credit Facility \| 2022 Revolving Credit Facility \| Credit Facility
Debt Instrument [Line Items]
Total	$ 0	$ 25,000,000

DEBT - Narrative (Details) - USD ($)	Sep. 29, 2023	Jun. 29, 2022	Jun. 07, 2022	Sep. 30, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Carrying amount				$ 620,312,000	$ 648,438,000
Interest rate swaps \| Designated as Hedging Instrument
Debt Instrument [Line Items]
Derivative instrument, term (in years)		5 years
Interest Rate Swap, First Three Years \| Designated as Hedging Instrument
Debt Instrument [Line Items]
Notional value of foreign currency forward contracts and interest rate swaps		$ 300,000,000
Interest Rate Swap, Years Four And Five \| Designated as Hedging Instrument
Debt Instrument [Line Items]
Notional value of foreign currency forward contracts and interest rate swaps		$ 150,000,000
Term Loan Facility \| 2022 Term Loan Facility
Debt Instrument [Line Items]
Principal amount of debt issued			$ 625,000,000
Debt instrument, term (in years)			7 years
Carrying amount				620,312,000	623,438,000
Mandatory amortization payment, percent per annum			1.00%
Prepayment without penalty percent of loan amount	1.00%
Term Loan Facility \| 2022 Term Loan Facility \| SOFR
Debt Instrument [Line Items]
Basis spread on variable rate	2.75%
Term Loan Facility \| 2022 Term Loan Facility \| Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate	1.75%
Credit Facility \| 2022 Revolving Credit Facility \| Revolving Credit Facility
Debt Instrument [Line Items]
Debt instrument, term (in years)			5 years
Maximum borrowing capacity			$ 700,000,000
Borrowings from lines of credit			135,000,000
Carrying amount				$ 0	$ 25,000,000
Credit Facility \| 2022 Revolving Credit Facility \| Letter of Credit
Debt Instrument [Line Items]
Maximum borrowing capacity			$ 100,000,000

COMMITMENTS AND CONTINGENCIES (Details) $ in Millions	9 Months Ended
COMMITMENTS AND CONTINGENCIES (Details) $ in Millions	Sep. 30, 2023 USD ($) location case	Dec. 31, 2022 USD ($)	Dec. 31, 2019 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Outstanding letters of credit, surety bonds and guarantees	$ 78.3	$ 82.4
Number of locations participating in assessments and remediation \| location	8
Accrued environmental liability	$ 5.9	$ 5.9	$ 2.0
Number of pending cases \| case	1

RESTRUCTURING EXPENSE - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Restructuring and Related Activities [Abstract]
Restructuring expense	$ 90	$ 69,755	$ 6,280	$ 84,859

RESTRUCTURING EXPENSE - Schedule of Restructuring Charges (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Restructuring Cost and Reserve [Line Items]
Restructuring expense	$ 90	$ 69,755	$ 6,280	$ 84,859
Cost of goods and services
Restructuring Cost and Reserve [Line Items]
Restructuring expense	29	66,488	2,573	67,496
Selling, general and administrative expense
Restructuring Cost and Reserve [Line Items]
Restructuring expense	61	3,267	3,707	17,363
Operating Segments \| Production Chemical Technologies
Restructuring Cost and Reserve [Line Items]
Restructuring expense	58	(335)	4,636	11,637
Operating Segments \| Production & Automation Technologies
Restructuring Cost and Reserve [Line Items]
Restructuring expense	0	4,282	785	260
Operating Segments \| Drilling Technologies
Restructuring Cost and Reserve [Line Items]
Restructuring expense	0	0	0	0
Operating Segments \| Reservoir Chemical Technologies
Restructuring Cost and Reserve [Line Items]
Restructuring expense	32	63,458	855	69,559
Corporate and other
Restructuring Cost and Reserve [Line Items]
Restructuring expense	$ 0	$ 2,350	$ 4	$ 3,403

RESTRUCTURING EXPENSE - Restructuring Reserve Rollforward (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2023 USD ($)
Restructuring Accrual Balance
Beginning balance	$ 28,518
Restructuring charges	6,280
Asset sales and write-offs	(705)
Payments	(17,432)
Other, including foreign currency translation	(3)
Ending balance	$ 16,658

STOCKHOLDERS' EQUITY (Details) - USD ($)			3 Months Ended						9 Months Ended
STOCKHOLDERS' EQUITY (Details) - USD ($)	Aug. 10, 2023	Feb. 16, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Oct. 24, 2022	Mar. 07, 2022
Stockholders' Equity Note [Abstract]
Approved quarterly cash dividend (in dollars per share)		$ 0.085
Dividends declared to common shareholders (in dollars per share)	$ 0.085		$ 0.085	$ 0.085	$ 0.085	$ 0.075	$ 0.075	$ 0.075
Dividends payable			$ 17,300,000						$ 17,300,000
Authorized amount of stock repurchase										$ 750,000,000	$ 250,000,000
Repurchase and cancellation of common stock			$ 68,113,000	$ 51,190,000	$ 40,427,000	$ 80,074,000	$ 20,016,000		$ 159,700,000

EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Earnings Per Share [Abstract]
Net income attributable to ChampionX	$ 77,711	$ 23,068	$ 237,040	$ 87,112
Weighted-average number of shares outstanding (in shares)	195,881	201,421	197,058	202,600
Dilutive effect of stock-based compensation (in shares)	3,711	5,101	3,967	5,555
Total shares and dilutive securities (in shares)	199,592	206,522	201,025	208,155
Earnings per share attributable to ChampionX:
Basic (in dollars per share)	$ 0.40	$ 0.11	$ 1.20	$ 0.43
Diluted (in dollars per share)	$ 0.39	$ 0.11	$ 1.18	$ 0.42
Number of antidilutive securities excluded (in shares)	200	400	400	400

ACQUISITIONS AND DIVESTITURES (Details) - USD ($)			3 Months Ended
ACQUISITIONS AND DIVESTITURES (Details) - USD ($)	Feb. 23, 2023	Feb. 23, 2022	Mar. 31, 2023	Sep. 30, 2023	Dec. 31, 2022	Mar. 31, 2022
Business Acquisition [Line Items]
Goodwill				$ 666,108,000	$ 679,488,000
Disposal Group, Held-for-sale, Not Discontinued Operations \| CT Russia Business
Business Acquisition [Line Items]
Recoverable value on divestiture			$ 0
Pre-tax impairment expense			$ 13,000,000
Leak Surveys, Inc.
Business Acquisition [Line Items]
Amount paid for acquisition	$ 500,000	$ 3,200,000
Future payments contingent upon performance		$ 2,500,000
Goodwill						$ 6,300,000

FAIR VALUE MEASUREMENTS - Assets And Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Assets
Derivative assets	$ 15,994	$ 15,542
Liabilities
Derivative liabilities	2,939	4,209
Level 2 \| Fair Value, Recurring
Assets
Derivative assets	15,994	15,542
Liabilities
Derivative liabilities	2,939	4,209
Foreign currency forward contracts \| Level 2 \| Fair Value, Recurring
Assets
Derivative assets	3,987	7,066
Liabilities
Derivative liabilities	2,939	4,209
Interest rate swaps \| Level 2 \| Fair Value, Recurring
Assets
Derivative assets	12,007	8,476
Liabilities
Derivative liabilities	$ 0	$ 0

FAIR VALUE MEASUREMENTS - Fair Value of Long-term Debt (Details) - Level 2 - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Carrying Amount \| 2022 Revolving Credit Facility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-term debt	$ 0	$ 25,000
Carrying Amount \| 2022 Term Loan Facility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-term debt	620,312	623,438
Fair Value \| 2022 Revolving Credit Facility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-term debt	0	25,000
Fair Value \| 2022 Term Loan Facility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-term debt	$ 627,291	$ 610,969

DERIVATIVES AND HEDGING TRANSACTIONS - Schedule of Fair Value of Derivative Instruments (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Derivative Assets
Derivative asset, current	$ 10,603	$ 11,911
Derivative asset, noncurrent	5,391	3,631
Derivative assets	$ 15,994	$ 15,542
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]	Prepaid expenses and other current assets	Prepaid expenses and other current assets
Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other Assets, Noncurrent	Other Assets, Noncurrent
Derivative Liabilities
Derivative liability, current	$ 2,939	$ 4,209
Derivative liabilities	$ 2,939	$ 4,209
Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued expenses and other current liabilities	Accrued expenses and other current liabilities

DERIVATIVES AND HEDGING TRANSACTIONS - Schedule of Derivative Instruments (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Foreign Exchange Forward Contracts and Interest Rate Swap
Derivative [Line Items]
Notional value of foreign currency forward contracts and interest rate swaps	$ 813,995	$ 965,973

DERIVATIVES AND HEDGING TRANSACTIONS - Schedule of Gain (Loss) on Derivative Instruments (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Total loss of derivative instruments	$ (1,057)	$ 915	$ (2,892)	$ 6,279
Cost of goods and services \| Designated as Hedging Instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Total loss of derivative instruments	(190)	(837)	(2,113)	(884)
Interest expense \| Designated as Hedging Instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Total loss of derivative instruments	(1,645)	585	(3,904)	585
Other (income) expense, net \| Not Designated as Hedging Instrument
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Total loss of derivative instruments	$ 778	$ 1,167	$ 3,125	$ 6,578

INVENTORIES (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Inventory, Net [Abstract]
Raw materials	$ 149,876	$ 142,571
Work in progress	18,092	19,582
Finished goods	505,053	467,628
Subtotal	673,021	629,781
Inventory reserve	(30,243)	(24,702)
LIFO adjustments	(53,978)	(62,536)
Inventories, net	$ 588,800	$ 542,543

ACCOUNTS RECEIVABLE FACILITY (Details) - Accounts receivable held for sale under Accounts Receivable Facility - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2023	Jun. 28, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]
Maximum accounts receivable that can be sold			$ 160.0
Accounts receivable sold		$ 543.4
Accounts receivable outstanding	$ 112.9	112.9
Loss on sale of trade receivable	$ 1.9	$ 5.3

SUPPLY CHAIN FINANCE (Details) $ in Millions	Sep. 30, 2023 USD ($)
Investments, Debt and Equity Securities [Abstract]
Supply chain finance outstanding	$ 45.4

CASH FLOW INFORMATION (Details) - USD ($) $ in Millions	9 Months Ended
CASH FLOW INFORMATION (Details) - USD ($) $ in Millions	Sep. 30, 2023	Sep. 30, 2022
Supplemental Cash Flow Elements [Abstract]
Transfers from inventory	$ 77.2	$ 32.1